What is the record date and share count for CRAI’s 2026 annual meeting?

The record date is May 22, 2026. Shareholders of record at the close of business that day may vote. At April 21, 2026, CRA International had 6,461,963 shares of common stock issued and outstanding, each entitled to one vote at the annual meeting.

Executive pay and board elections at CRA International (NASDAQ: CRAI)

Q: What key items will CRAI shareholders vote on at the 2026 annual meeting?

Shareholders will vote on three main proposals. These are electing two Class I directors to three-year terms, approving on an advisory basis the compensation of named executive officers, and ratifying Grant Thornton LLP as independent registered public accountants for the fiscal year ending January 2, 2027.

Q: How are CRAI’s non-employee directors compensated?

Non-employee directors receive cash retainers and equity. In fiscal 2025, each received an $85,000 annual board fee, additional cash for committee and lead director roles, and a restricted stock award valued at about $125,000, vesting over four years to support long-term alignment with shareholders.

Q: Who are CRAI’s largest institutional shareholders above 5% ownership?

Several institutions hold more than five percent stakes. FMR LLC reports beneficial ownership of 583,841 shares (9.0%), BlackRock, Inc. holds 501,133 shares (7.8%), and Copeland Capital Management, LLC holds 361,270 shares (5.6%), based on recent Schedule 13G and 13G/A filings.

Q: Where will CRAI’s 2026 annual meeting be held and how can materials be accessed?

The meeting will be held at CRA’s Boston offices. The location is 200 Clarendon Street, 9th Floor, Boston, Massachusetts, at 8:00 a.m. eastern daylight time on July 16, 2026. The proxy statement and 2025 annual report will be available at www.edocumentview.com/CRAI by May 29, 2026.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

DEF 14A

Rhea-AI Filing Summary

CRA International, Inc. will hold its annual shareholder meeting on July 16, 2026 in Boston. Shareholders will vote on electing two Class I directors, an advisory say‑on‑pay resolution for executive compensation, and ratifying Grant Thornton LLP as independent auditors for the fiscal year ending January 2, 2027.

The record date is May 22, 2026, with 6,461,963 common shares outstanding. The company highlights a largely independent board, detailed committee structure, and a pay‑for‑performance program mixing salary, annual cash bonuses, and long‑term equity awards, plus stock ownership guidelines and a clawback policy to align executives with shareholders.

Key Figures

Shares outstanding: 6,461,963 shares Share price: $156.43 per share FMR LLC stake: 583,841 shares (9.0%) +5 more

8 metrics

Shares outstanding 6,461,963 shares Common stock outstanding as of April 21, 2026

Share price $156.43 per share Closing price on Nasdaq Global Select Market on April 21, 2026

FMR LLC stake 583,841 shares (9.0%) Beneficial ownership of CRAI common stock

BlackRock stake 501,133 shares (7.8%) Beneficial ownership of CRAI common stock

Copeland Capital stake 361,270 shares (5.6%) Beneficial ownership of CRAI common stock

Director cash retainer $85,000 per year Annual fee paid to each non-employee director in fiscal 2025

Restricted stock award to directors 696 shares (~$124,939) Grant to each non-employee director on July 17, 2025

Director and officer holdings 291,692 shares (4.5%) All current directors and executive officers as a group

Key Terms

say-on-pay, audit committee financial expert, performance-vesting restricted stock units, clawback policy, +2 more

6 terms

say-on-pay financial

"To conduct an advisory vote to approve our executive compensation"

A say-on-pay is a shareholder vote that gives investors a chance to approve or disapprove a company’s executive compensation packages, typically held at annual meetings. It matters because the vote signals investor satisfaction with how leaders are paid—like customers rating how well managers are rewarded—and can push boards to change pay plans, reducing governance risk and affecting investor confidence and stock value even though the vote is usually advisory rather than legally binding.

audit committee financial expert financial

"our board of directors has determined that it currently has two audit committee financial experts"

A person on a company’s board who has deep knowledge of accounting, financial reporting and auditing, able to understand and question the books, controls and audit work like a trained mechanic inspecting an engine. Investors care because that expertise helps spot errors, weaknesses or misleading statements early, improving the likelihood that financial reports are accurate and reducing the risk of surprises that can hurt a company’s value.

performance-vesting restricted stock units financial

"include performance-vesting restricted stock units (“PRSUs”) and performance-based cash awards"

Performance-vesting restricted stock units are a form of employee pay where future company shares are granted only if the business meets specific targets, such as revenue, profit, or stock-price goals. Think of them as a bonus you earn only when certain milestones are hit; for investors they matter because they can increase the number of shares outstanding if goals are met and they reveal how management is being motivated to hit particular financial or operational objectives.

clawback policy financial

"our board of directors adopted a policy for the recovery of erroneously awarded compensation"

A clawback policy is a company rule that lets the firm take back pay, bonuses or stock awards from current or former executives if results are later found to be incorrect, misconduct occurred, or targets were missed. It matters to investors because it helps protect the value of their holdings by discouraging risky or fraudulent behavior and ensuring executive rewards reflect real, verified performance—think of it as a return policy for executive pay.

enterprise risk management financial

"oversight of our enterprise risk management by providing recommendations to our board of directors"

Enterprise Risk Management is a process companies use to identify, assess, and prepare for potential problems that could disrupt their success, like financial losses or reputation damage. It’s like a safety plan that helps a business stay strong and adapt quickly when unexpected challenges come up. This helps the company protect its future and keep running smoothly.

Lead Director financial

"our board elected Christine Detrick as the new independent Lead Director"

A lead director is a board member chosen by other independent directors to coordinate the board’s independent oversight of company management, acting like a team captain or referee who organizes meetings, leads discussions without the CEO present, and serves as a primary contact between independent directors and company leadership. Investors care because a strong lead director helps prevent conflicts of interest, improves decision-making and accountability, and signals that the board is actively watching how management runs the business.

Compensation Summary

Compensation details

Key Proposals

Election of two Class I directors to three-year terms
Advisory vote to approve executive compensation
Ratification of Grant Thornton LLP as independent registered public accountants

Proxy Statements (DEF 14A): Pay, Votes, and Board Changes →

04/24/2026 - 04:10 PM

TABLE OF CONTENTS

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 14A

Proxy Statement Pursuant to Section 14(a) of
the Securities Exchange Act of 1934

Filed by the Registrant ☒

Filed by a Party other than the Registrant ☐

Check the appropriate box:

☐

Preliminary Proxy Statement

☐

Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

☒

Definitive Proxy Statement

☐

Definitive Additional Materials

☐

Soliciting Material under §240.14a-12

CRA INTERNATIONAL, INC.

(Name of Registrant as Specified In Its Charter)

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check the appropriate box):

No fee required.

☐

Fee paid previously with preliminary materials.

☐

Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11

TABLE OF CONTENTS

CRA INTERNATIONAL, INC.

Notice of Annual Meeting of Shareholders
to be held on July 16, 2026

CRA International, Inc. hereby gives notice that it will hold an annual meeting of shareholders at its offices at 200 Clarendon Street, 9th Floor, Boston, Massachusetts 02116, on Thursday, July 16, 2026, at 8:00 a.m., eastern daylight time. The annual meeting is being held for the following purposes:

To consider and vote upon the election of two Class I directors;

To conduct an advisory vote to approve our executive compensation;

To ratify the appointment by our audit committee of Grant Thornton LLP as our independent registered public accountants for our fiscal year ending January 2, 2027; and

To transact such further business as may properly come before the annual meeting or any adjournment thereof.

Our board of directors has fixed the close of business on Friday, May 22, 2026, as the record date for the determination of our shareholders entitled to receive notice of, and to vote at, the annual meeting and any adjournment thereof. Only shareholders of record on May 22, 2026, are entitled to receive notice of, and to vote at, the annual meeting or any adjournment thereof.

By order of the board of directors,

Jonathan Yellin

Secretary

Boston, Massachusetts
April 24, 2026

YOUR VOTE IS IMPORTANT
Please sign and return the enclosed proxy, whether or not you
plan to attend the annual meeting.

IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS
FOR THE ANNUAL MEETING
OF SHAREHOLDERS TO BE HELD ON JULY 16, 2026:
The Proxy Statement and 2025 Annual Report to Shareholders
will be, on or prior to May 29, 2026, available at

www.edocumentview.com/CRAI

TABLE OF CONTENTS

CRA INTERNATIONAL, INC.

200 Clarendon Street
Boston, Massachusetts 02116
(617) 425-3000

PROXY STATEMENT
ANNUAL MEETING OF SHAREHOLDERS
to be held on July 16, 2026

This proxy statement relates to the 2026 annual meeting of shareholders of CRA International, Inc. (“we,” “us,” “our,” “CRA” or the “Company”). The annual meeting will take place at our Boston offices as follows:

Date:

July 16, 2026

Time:

8:00 a.m.

Place:

CRA International, Inc.
200 Clarendon Street
9th Floor
Boston, Massachusetts 02116

Our board of directors is soliciting proxies for the annual meeting and any and all adjournments of the annual meeting. The shares represented by your properly signed proxy will be voted in accordance with your directions. If you are a registered holder and do not specify a choice with respect to a proposal for which our board of directors has made a recommendation, the shares covered by your signed proxy will be voted as recommended in this proxy statement. We encourage you to vote on all matters to be considered. You may revoke your proxy at any time before it has been exercised.

This proxy statement will be made available to shareholders on or prior to May 29, 2026 on the Internet at www.edocumentview.com/CRAI.

TABLE OF CONTENTS

PROXY STATEMENT

TABLE OF CONTENTS

	Page
ANNUAL MEETING OF SHAREHOLDERS		1
Purpose of the annual meeting		1
Record date		1
Quorum		1
Vote required; tabulation of votes; revocation of proxy		1
Solicitation of proxies		2
Internet access to proxy materials		2
Directions to our offices		2
PROPOSAL ONE: ELECTION OF DIRECTORS		3
CORPORATE GOVERNANCE		4
Overview		4
Executive officers and directors		5
Board and committee meetings		8
Audit committee		9
Nominating and corporate governance committee		9
Compensation committee		10
Executive committee		10
Board leadership structure and role in risk oversight		10
Director candidates and selection process		11
Communications with our board of directors		12
TRANSACTIONS WITH RELATED PERSONS		12
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT		13
COMPENSATION OF DIRECTORS AND EXECUTIVE OFFICERS		15
Director compensation		15
Director stock ownership guidelines		16
Compensation committee interlocks and insider participation		16
Compensation discussion and analysis		17
Compensation policies and practices as they relate to risk management		32
Executive compensation		33
CEO Pay Ratio		51
Pay Versus Performance Table		52
PROPOSAL TWO: ADVISORY VOTE ON EXECUTIVE COMPENSATION		56
EQUITY COMPENSATION PLANS		57
REPORT OF THE AUDIT COMMITTEE		58
PROPOSAL THREE: RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTANTS		59
Overview		59
PRINCIPAL ACCOUNTANT FEES AND SERVICES		60
Fees and Services		60
Pre-approval policies and procedures		60
SHAREHOLDER PROPOSALS		61
AVAILABLE INFORMATION		61

TABLE OF CONTENTS

ANNUAL MEETING OF SHAREHOLDERS

Purpose of the annual meeting

At the annual meeting, we will submit the following proposals to our shareholders:

Proposal One: To elect two Class I directors to a three-year term;

Proposal Two: To approve, on an advisory basis, the compensation paid to our named executive officers, as disclosed in this proxy statement pursuant to Item 402 of Regulation S-K (including in the compensation discussion and analysis, compensation tables and accompanying narrative disclosures);

Proposal Three: To ratify the appointment by our audit committee of Grant Thornton LLP as our independent registered public accountants for our fiscal year ending January 2, 2027.

Our board of directors does not intend to present to the annual meeting any business other than the proposals described in this proxy statement. Our board of directors was not aware, a reasonable time before making this proxy statement available to our shareholders, of any other business that properly may be presented for action at the annual meeting. If any other business should come before the annual meeting, the persons present will have discretionary authority to vote the shares they own or represent by proxy in accordance with their judgment, to the extent authorized by applicable regulations.

Record date

Our board of directors has fixed the close of business on Friday, May 22, 2026, as the record date for the annual meeting. Only shareholders of record at the close of business on that date are entitled to receive notice of the annual meeting and to vote at the annual meeting. At the close of business on Tuesday, April 21, 2026, 6,461,963 shares of our common stock were issued and outstanding. A list of the shareholders entitled to notice of the annual meeting will be available to shareholders for inspection for the duration of the annual meeting of shareholders.

Quorum

Our by-laws provide that a quorum at the annual meeting consists of a majority in interest of all shares of our common stock issued, outstanding and entitled to vote at the annual meeting. Shares of our common stock represented by a properly signed and returned proxy will be treated as present at the annual meeting for purposes of determining the existence of a quorum at the annual meeting. In general, votes withheld from any nominee for election as director, abstentions, and broker “non-votes” are counted as present or represented for purposes of determining the existence of a quorum at the annual meeting. A broker non-vote occurs when a broker or nominee holding shares for a beneficial owner returns a proxy but does not vote on a proposal because the broker or nominee does not have discretionary voting power, and has not received instructions from the beneficial owner, with respect to the proposal.

Vote required; tabulation of votes; revocation of proxy

A plurality of the votes properly cast at the annual meeting will be necessary to elect the two Class I directors to a three-year term.

A majority of the votes properly cast at the annual meeting will be necessary to approve, on an advisory basis, the compensation paid to our named executive officers (as disclosed in this proxy statement pursuant to Item 402 of Regulation S-K) and to ratify the appointment by our audit committee of Grant Thornton LLP as our independent registered public accountants for our fiscal year ending January 2, 2027.

Abstentions and broker non-votes will not be considered when determining whether or not the necessary proportion of votes properly cast at the annual meeting on any proposal was achieved. If you are a registered shareholder and you return an executed proxy with specific instructions on how to vote, the designated proxies will vote according to your instructions. However, if you are a registered shareholder and you return an executed proxy without specific instructions on how to vote, the designated proxies will vote

TABLE OF CONTENTS

in accordance with the recommendations of our board of directors set forth in this proxy statement. You may revoke your proxy at any time before it has been exercised.

Each share of our common stock outstanding on the record date will be entitled to cast one vote. Our transfer agent, Computershare, will tabulate the votes at the annual meeting.

Solicitation of proxies

Our board of directors is soliciting proxies for the annual meeting and any and all adjournments of the annual meeting. No compensation will be paid by any person in connection with our solicitation of proxies. We will reimburse brokers, banks and other nominees for the out-of-pocket expenses and other reasonable clerical expenses they incur in obtaining instructions from beneficial owners of our common stock. In addition to our solicitation by mail, our directors, officers and other employees may make special solicitations of proxies personally or by telephone, facsimile, courier or e-mail. We expect that the expense of any special solicitations will be nominal, and we will pay all expenses incurred in connection with them.

Internet access to proxy materials

The notice of annual meeting, this proxy statement and our 2025 annual report to shareholders will be, on or prior to May 29, 2026, available on the Internet at www.edocumentview.com/CRAI. This website does not use “cookies” to track or identify visitors to the website.

Directions to our offices

The annual meeting will be held at our offices at 200 Clarendon Street, 9th Floor, Boston, Massachusetts.

For those planning to attend the annual meeting, directions to these offices are below.

•

From Logan International Airport: Follow the signs to Boston through the Sumner Tunnel. Turn right up the entrance ramp onto Expressway I-93 North. Take the Storrow Drive exit on right. Follow Storrow Drive West and take the Copley Square exit on the left. Turn right at the set of lights onto Beacon Street. At the second set of lights, turn left onto Clarendon Street and proceed for five blocks.

•

From Points South via 1-95 and 1-93: Follow I-95 North to Expressway I-93 North. Stay on I-93 through the tunnel and into the financial district. Take the Storrow Drive exit on the right. Follow Storrow Drive West and take the Copley Square exit on the left. Turn right at the set of lights onto Beacon Street. At the second set of lights, turn left onto Clarendon Street and proceed for five blocks.

•

From Western Massachusetts and Points South via the Mass. Pike: Follow Mass. Pike (I-90) East to the Copley Square/Prudential Center exit 133 (old exit 22). Follow the Copley Square exit and take the first left onto Dartmouth Street. Turn right onto Boylston Street. Turn right onto Clarendon Street.

•

From Points North via 1-95 or 1-93: Follow I-95 South to I-93 South. Take exit 18 (old exit 26), North Station/Storrow Drive. Follow Storrow Drive West and take the Copley Square exit on the left. Turn right at the set of lights onto Beacon Street. At the second set of lights, turn left onto Clarendon Street and proceed for five blocks.

•

From Public Transportation: The public transportation locations nearest to our offices are Back Bay Station (Orange Line, Commuter Rail and Amtrak) and Copley Station (Green Line).

•

Parking: There are several parking areas along Clarendon Street. There is an underground garage on the left between Boylston Street and St. James Avenue. There is a parking garage on the right one block past 200 Clarendon Street. If those are full, proceed down Clarendon Street, take a right on Columbus Avenue, take a right on Dartmouth Street and there is an underground garage on the left at the Tent City building. Additional parking can be found at the Copley Place Mall.

TABLE OF CONTENTS

PROPOSAL ONE:
ELECTION OF DIRECTORS

Proposal One concerns the election of two Class I directors.

Our board of directors currently consists of eight directors and is divided into three classes. We refer to these classes as Class I, Class II and Class III. The term of one class of directors expires each year at the annual meeting of our shareholders. Each director also continues to serve as a director until his or her successor is duly elected and qualified. This year, the term of the Class I directors is expiring.

Accordingly, our board of directors has nominated Richard Booth and Christine Detrick to serve as Class I directors for a three-year term. Our shareholders elected Mr. Booth and Ms. Detrick as Class I directors at our annual meeting of shareholders in July 2023. The current terms of Mr. Booth and Ms. Detrick will expire at the annual meeting. William Concannon, a Class I director, will retire from the board of directors effective as of the adjournment of the 2026 annual meeting and the size of the board of directors will be reduced to seven directors.

Proxies will not be voted at the annual meeting for more than two candidates.

Mr. Booth and Ms. Detrick have agreed to serve if elected, and we have no reason to believe that either of them will be unable to serve. If either of them is unable or declines to serve as a director at the time of the annual meeting, proxies will be voted for another nominee designated by our board of directors at that time.

Our board of directors recommends that you vote FOR the election of Mr. Booth and Ms. Detrick.

TABLE OF CONTENTS

CORPORATE GOVERNANCE

Overview

In designing our corporate governance structure, we seek to identify and implement the practices that we believe will best serve the interests of our business and shareholders, including the practices mandated by the Sarbanes-Oxley Act and the Dodd-Frank Wall Street Reform and Consumer Protection Act, and the related rules of the Securities and Exchange Commission and the Nasdaq Global Select Market. You can find our current corporate governance principles, including our code of business conduct and ethics, our statement of corporate governance guidelines, and the charters for the standing committees of our board of directors through the Investor Relations page of our website at www.crai.com. Our code of business conduct and ethics applies not only to our principal executive officer, principal financial officer and principal accounting officer, but also to all of our other officers and employees, directors and outside consultants. Our code of business conduct and ethics includes, among other things, provisions covering compliance with law, rules and regulations, conflicts of interest, insider trading, fair dealing, proper use of our assets, confidentiality, health and safety, discrimination and harassment, accounting and record keeping, and the reporting of illegal or unethical behavior. We intend to continue to modify our policies and practices to address ongoing developments in the area of corporate governance. We discuss many features of our corporate governance principles in other sections of this proxy statement. Some of the highlights of our corporate governance principles are the following:

•

Director and committee independence. With the exception of Mr. Maleh, our president, chief executive officer and chairman of the board, all of our directors (including Mr. Concannon, who is not standing for reelection at the annual meeting, and Mr. Booth and Ms. Detrick, each of whom are standing for election at the annual meeting) are independent directors under the rules of the Nasdaq Global Select Market. Our board of directors has determined that our independent directors under these rules are Drs. Tookes and Taylor, Messrs. Avery, Booth and Concannon, and Mses. Detrick and Keenan. Each member of our audit committee, nominating and corporate governance committee, and compensation committee meets the independence requirements of the Nasdaq Global Select Market for membership on the committees on which he or she serves.

•

Audit committee. Our audit committee is directly responsible for appointing, determining the compensation of, evaluating and, when necessary, terminating our independent registered public accountants. Our independent registered public accountants report directly to our audit committee. Our board of directors has determined that it currently has two audit committee financial experts as defined under the rules of the Securities and Exchange Commission. Our audit committee’s prior approval is required for all audit services and non-audit services (other than de minimis non-audit services as defined by the Sarbanes-Oxley Act) to be provided by our independent registered public accountants. The audit committee has delegated the authority to provide such pre-approval to its chair if the chair determines in good faith that the applicable services would not impair the independence of our independent registered public accountants. Our audit committee is responsible for reviewing and assessing the adequacy of its charter on an annual basis.

•

Compensation committee. Our compensation committee is responsible for recommending to our board of directors our general compensation philosophy and policies, and for reviewing and approving (or recommending to our board of directors for approval) the compensation of our executive officers, directors and other members of our senior management. The compensation committee is also directly responsible for appointing, determining the compensation of, overseeing and evaluating the independence of our compensation consultants. Our compensation committee is responsible for reviewing and assessing the adequacy of its charter on an annual basis.

•

Nominating and corporate governance committee. Our nominating and corporate governance committee is responsible for identifying and recommending to our board of directors individuals qualified to become members of our board of directors, succession planning for our board of directors, and for recommending directors for appointment to the committees of our board of directors. The nominating and corporate governance committee is also responsible for overseeing our corporate governance guidelines and practices, including matters relating to board evaluation and succession planning for our chief executive officer and other senior officers. Our nominating and corporate

TABLE OF CONTENTS

governance committee is responsible for reviewing annually any need for changes in the number, charters, or titles of board committees.

•

Executive committee. Our executive committee has delegated authority to act on behalf of our board of directors in situations arising between regular meetings of our board of directors, with meetings to be called by the chief executive officer. The executive committee is intended to act only when reasonably necessary to expedite the interest of the Company between regularly scheduled meetings of the board of directors, and does not have responsibility for matters that are required by law, regulation or our corporate governance guidelines to be considered by the full board of directors or another committee of the board.

•

Committee authority. Each of our audit committee, nominating and corporate governance committee, and compensation committee has the authority to retain independent advisors and consultants, with all fees and expenses paid by us.

•

Whistleblower procedures. Our audit committee has adopted procedures for the treatment of complaints regarding accounting, internal control over financial reporting or auditing matters, including procedures for the confidential and anonymous submission by our directors, officers, employees and outside consultants of concerns regarding questionable accounting, internal control over financial reporting or auditing matters.

Executive officers and directors

Set forth below are the names and certain information with respect to each of our directors, nominees for director and executive officers as of April 21, 2026:

Name	Age	Position
Paul Maleh	62	President, chief executive officer and chairman of the board
Eric Nierenberg*	51	Executive vice president, chief financial officer and treasurer
Chad Holmes**	53	Executive vice president and chief corporate development officer
Jonathan Yellin	62	Executive vice president and general counsel
Brian Langan***	46	Executive vice president and chief strategy and business transformation officer
Thomas Avery	72	Director
Richard Booth	56	Director
Christine Detrick	67	Director
Karen Keenan	63	Director
Alva Taylor	65	Director
Heather Tookes	52	Director

Dr. Nierenberg was appointed to executive vice president, chief financial officer and treasurer, effective August 2025.

Mr. Holmes assumed the role of interim chief financial officer and treasurer following the departure of Daniel Mahoney, who resigned as executive vice president, chief financial officer and treasurer effective April 2025. Mr. Holmes relinquished this role in connection with the appointment of Dr. Nierenberg, effective August 2025.

***

Mr. Langan was appointed to executive vice president and chief strategy and business transformation officer, effective August 2025.

Our board of directors is divided into three classes. The term of one class of directors expires each year at the annual meeting of our shareholders. Each director also continues to serve as a director until his or her successor is duly elected and qualified. Our executive officers are elected by, and serve at the discretion of, our board of directors. There are no family relationships among our directors and executive officers.

TABLE OF CONTENTS

Backgrounds and qualifications of directors

Below we have identified each of our directors by class. In addition, for each director we have included information regarding the director’s business experience, as well as the director’s particular experiences, qualifications, attributes and skills that led our board of directors to conclude that the director should serve as a member of our board of directors.

Directors serving a term expiring at the 2026 annual meeting (Class I directors)

Richard Booth has served as a director since March 2020. From March 2021 to June 2025 he served as chief financial officer of Definitive Healthcare Corp. (Nasdaq: DH), a data analytics company. From April 2015 to March 2021, Mr. Booth served as chief financial officer of Bottomline Technologies, Inc., a financial technology company. From January 2014 to March 2015, Mr. Booth served as vice president of finance and corporate controller at Sapient Corporation. Previously, he held a number of senior finance positions of increasing responsibility at Nuance Communications (Nasdaq: NUAN), a publicly traded software and services firm. Prior to his tenure at Nuance, Mr. Booth held a variety of executive roles at EMC Corporation, Mercer Management Consulting, and Coopers & Lybrand. Mr. Booth is a licensed CPA, and holds an M.B.A. from Stanford University, an M.S. in Taxation from Bentley University, an M.S. in Organizational Development from American University, and a B.S. in Accounting from Pennsylvania State University. Our board benefits greatly from Mr. Booth’s extensive accounting and finance expertise, his knowledge of the consulting and technology industries, and his perspective gained from having served as a business executive and chief financial officer. Our board of directors has determined that Mr. Booth is an audit committee financial expert under the rules of the Securities and Exchange Commission.

Christine Detrick has served as a director since May 2020. From 2002 to 2012, Ms. Detrick served as a director/partner of Bain & Company (“Bain”), as leader of the financial services practice for the Americas, and a senior advisor. Before joining Bain, she served for 10 years at A.T. Kearney, Inc., including as global leader of the Financial Institutions Group, leader of the Eastern U.S., and as a member of the board of management and board of directors. Prior to those roles, she was one of the founding partners of First Financial Partners, a venture capital firm specializing in savings and loan institutions, from 1988 to 1992, and served as the chief executive officer of the St. Louis Bank for Savings. Ms. Detrick also serves on the board of directors of Hartford Mutual Funds, a mutual fund company, including as chair of the board of directors and a member of the nominating and corporate governance committee. Ms. Detrick also serves on the board of directors of Capital One (NYSE: COF), a publicly traded financial institution, serving on the audit and risk committees. From December 2021 to April 2025, Ms. Detrick served on the board of directors of Altus Power, a solar energy company, serving as chair of the board of directors and a member of the executive and nominating and governance committees. Ms. Detrick also served on the board of directors of Reinsurance Group of America (NYSE: RGA), a publicly traded reinsurance company, serving as chair of the nominating and governance committee and a member of the compensation and technology and cyber committees from 2014 to 2022. From 2015 to 2018, Ms. Detrick served on the board of directors of Forest City Realty Trust (NYSE:FCE-A), a publicly traded real estate investment trust, as chair of the compensation committee and a member of the nominating and corporate governance committee. Ms. Detrick received her B.S. in Economics from the Wharton School of the University of Pennsylvania in 1980. Our board benefits greatly from Ms. Detrick’s deep experience as both a director and an executive of financial services and management consulting firms, including as a chief executive officer, corporate board member and committee member.

Directors serving a term expiring at the 2027 annual meeting (Class II directors)

Alva Taylor, Ph.D., has served as a director since August 2022. Dr. Taylor has been a professor since 2000, the faculty director of the Glassmeyer/McNamee Center for Digital Strategies at the Tuck School of Business at Dartmouth College since 2013, and the Senior Associate Dean of Executive Learning since 2025. Dr. Taylor is Dean of all of Tuck’s learning programs focused on applying Tuck’s educational thought leadership to help executives and companies increase their performance and success. The Center for Digital Strategies helps business leaders understand how changes in digital technology impact business strategy and corporate decision making. Dr. Taylor has been recognized for his research in the areas of innovation processes, entrepreneurship, technological change, and strategic decision making in fast-changing

TABLE OF CONTENTS

environments. His recent work explores the challenges of managing creative groups for sustained innovation and entrepreneurship, and how organizational learning takes place in information-rich environments. He teaches courses on strategy, innovation, and change management in Tuck’s flagship MBA, Executive Education, and Master’s in Health Care Delivery Science programs. Dr. Taylor has also served as a board member of the Cardigan Mountain School in Canaan, New Hampshire, since September 2022. Dr. Taylor earned his B.S. and M.S. in Operations Research and Industrial Engineering and his M.B.A. from Cornell University, and earned his Ph.D. from Stanford University. Our board values and has benefited greatly from Dr. Taylor’s expertise in the areas of digital strategy and change management.

Heather Tookes, Ph.D., has served as a director since December 2022. Dr. Tookes currently serves as a finance professor at the Yale School of Management, a leader in business education, and has been on the faculty of the Yale School of Management since 2004. Dr. Tookes also currently serves on the boards of Dimensional Funds (DFA Investment Dimensions Group Inc., Dimensional Investment Group Inc., DFA Investment Trust Company, Dimensional Emerging Markets Value Fund, and Dimensional ETF Trust, each of which is a registered investment company), a shareholder of the Company, and Ariel Investments LLC, a registered investment advisor. Since January 2022, Dr. Tookes has served as a director of the Community Foundation of Greater New Haven. From June 2021 to March 2023, Dr. Tookes served as a director of Payoneer Global Inc. (Nasdaq: PAYO), a financial services company. Dr. Tookes has a B.A. in Economics from Brown University and a Ph.D. in Management (Finance) from Cornell University. In addition to being an expert in corporate finance, Dr. Tookes brings a wealth of board experience from having served on a number of nonprofit, private and public company boards.

Karen Keenan has served as a director since January 2024. Ms. Keenan’s 35-year career in financial services has included leadership roles in finance and controls, risk management, regulatory compliance, and business management. Ms. Keenan previously worked at State Street Corporation for 13 years, rising through the bank’s Global Markets Division, which provides investment research and trading services to institutional investors. From 2016 until her retirement in 2020, she served as State Street’s Chief Administrative Officer. Before joining State Street, she served as Chief Financial Officer for Investors Financial Services Corporation for six years. Ms. Keenan is a CPA and since 2020 has served as an independent director on the board of CLS Group Holdings AG, which provides foreign exchange settlement services to member banks. Ms. Keenan has a B.S. in accountancy from Bentley University and an M.B.A. in finance from Babson College. Our board of directors has determined that Ms. Keenan is an audit committee financial expert under the rules of the Securities and Exchange Commission. Our board benefits from Ms. Keenan’s deep experience in finance, controls, and risk oversight, including her service as a chief financial officer and as chief administrative officer of a global financial services institution, which supports the board’s oversight of financial reporting, compliance, and enterprise risk management.

Directors serving a term expiring at the 2028 annual meeting (Class III directors)

Paul Maleh, who joined us in 1989, has served as our president and chief executive officer and as a director since November 2009, and became chairman of our board of directors in July 2020. Mr. Maleh served as our chief operating officer from October 2008 through November 2009, and as our executive vice president from October 2006 to November 2009. Mr. Maleh has also served as a board member of KIPP Massachusetts, a non-profit charter school since September 2022. From December 2006 to January 2009, he served as head of our finance platform. Mr. Maleh also directed our finance practice from 2000 to December 2006 and served as a vice president from 1999 to October 2006. Mr. Maleh received his M.B.A. from Northeastern University. As our chief executive officer, Mr. Maleh brings to our board of directors valuable leadership experience and a deep and thorough understanding of our business and operations, the day-to-day management of our business, and our industry as a whole.

Thomas Avery has served as a director since February 2016. Mr. Avery served as a managing director at Raymond James & Associates from August 2000 to December 2014. Prior to joining Raymond James, Mr. Avery was head of the investment banking group and co-head of the equity capital markets division at Interstate/Johnson-Lane from 1995 to 2000, a general partner at Noro-Moseley Partners from 1989 to 1995, and a general partner at Summit Partners from 1984 to 1989. From 1977 to 1984, Mr. Avery served as senior vice president of The Robinson-Humphrey Company. Mr. Avery has served on the board of directors of ArborGen Inc., a biotechnology tree seedling company, since July 2018. He also serves on the advisory

TABLE OF CONTENTS

board for the Scheller College of Business at the Georgia Institution of Technology, and serves as a director of KIPP Metro Atlanta, a charter school organization serving low-income, minority children in Atlanta, Georgia, as well as PowerUp, a 501(c)(3) organization also serving low-income, minority children in Atlanta, Georgia. Mr. Avery served on the board of directors of Cicero, Inc. from July 2015 to 2020. Mr. Avery has a B.S. in industrial management from the Georgia Institute of Technology and an M.B.A. from Harvard Business School. Our board of directors values Mr. Avery’s significant investment banking and venture capital experience, as well as his deep understanding of the professional services industry.

Backgrounds of executive officers

Below we identify our executive officers (other than Mr. Maleh, our president and chief executive officer, who is our chairman of the board and serves as a Class III director as identified above) and provide a description of their business experience.

Chad Holmes, who joined us in 2004 as part of our acquisition of InteCap, Inc., has served as our executive vice president and chief corporate development officer since 2020. Mr. Holmes previously served as our executive vice president, chief financial officer and treasurer from 2014 through 2020 and served as interim chief financial officer and treasurer from April 2025 to August 2025. He has been a member of our senior management since 2009. Mr. Holmes received his M.B.A. in finance and management and strategy from the Kellogg School of Management at Northwestern University and his B.A. in economics from the University of Notre Dame.

Brian Langan has served as our executive vice president and chief strategy and business transformation officer since August 2025. Mr. Langan previously served as vice president in the Company’s Competition and Labor & Employment group from March 2019 through August 2025, as a manager in the Company’s Financial Planning & Analysis group, and in a number of roles supporting the Company’s senior management team. He joined the Company in 2002 as a consultant in the Antitrust & Competition Economics Practice. Mr. Langan holds a B.A. in Economics and an M.B.A. from Boston College.

Eric Nierenberg has served as our executive vice president, chief financial officer and treasurer since August 2025. Dr. Nierenberg joined the Company’s senior management team as a vice president in 2023. From 2017 to 2022, he served as Chief Strategy Officer for MassPRIM, the Massachusetts state pension fund. Prior to that, he was an equity portfolio manager at LMCG Investments and Independence Investments. Dr. Nierenberg is a Board member of investment funds dedicated to the Hydro-Québec Pension Fund. He also is an adjunct professor of finance at the International Business School of Brandeis University. He started his career as an analyst in the Company’s Finance Practice. Dr. Nierenberg holds a B.A. and M.A. in economics, as well as a Ph.D. in business economics, all from Harvard University.

Jonathan Yellin has served as our executive vice president and general counsel since March 2017. Mr. Yellin has been a member of our senior management since 2004, when he joined us as vice president and general counsel. Prior to joining us, Mr. Yellin was a senior partner in the Insolvency and Restructuring practice at Riemer & Braunstein LLP, from 1999 to 2004. Mr. Yellin received his J.D. cum laude from the University of Miami School of Law in 1988 and his B.A. from The George Washington University, School of Public and International Affairs, in 1985.

Board and committee meetings

During our fiscal year ended January 3, 2026, or “fiscal 2025,” our board of directors met five times and acted by unanimous written consent seven times. During fiscal 2025, each incumbent director attended at least 75% of the total number of meetings held by our board of directors and the committees of our board of directors on which he or she served. To the extent reasonably practicable, directors are expected to attend or participate by teleconference in board meetings, meetings of committees on which they serve and the annual meeting of our shareholders. Last year, all eight individuals then serving as directors attended the annual meeting of our shareholders.

Our board of directors has four standing committees: our audit committee, our nominating and corporate governance committee, our compensation committee and our executive committee. All of the members of our audit committee, our nominating and corporate governance committee, and our

TABLE OF CONTENTS

compensation committee are independent under the rules of the Nasdaq Global Select Market. Our board of directors has adopted written charters for each of these committees, which are available through the Investor Relations page of our website at www.crai.com. Each of our audit committee, our nominating and corporate governance committee, and our compensation committee has the authority to retain independent advisors and consultants, with all fees and expenses paid by us.

The membership of each standing committee of our board of directors is as follows:

	Audit committee:			Compensation committee:
	Richard Booth (Chair)			Heather Tookes, Ph.D. (Chair)
	Karen Keenan			Thomas Avery
	Alva Taylor, Ph.D.			William Concannon*
				Christine Detrick
	Nominating and corporate governance committee:			Executive committee:
	Christine Detrick (Chair)			Paul Maleh (Chair)
	William Concannon*			Richard Booth
	Alva Taylor, Ph.D.			William Concannon*
	Heather Tookes, Ph.D.			Christine Detrick

Mr. Concannon will retire from the board of directors effective as of the adjournment of the 2026 annual meeting.

Audit committee

During fiscal 2025, our audit committee was composed of Mr. Booth, Ms. Keenan and Dr. Taylor. Our audit committee provides the opportunity for direct contact between the members of our board of directors and our independent registered public accountants, which report directly to the committee. The committee assists our board of directors in overseeing the integrity of our financial statements; our compliance with legal and regulatory requirements; and our independent registered public accountants’ qualifications, independence and performance. The committee is directly responsible for appointing, determining the compensation of, evaluating and, when necessary, terminating our independent registered public accountants. The committee is also responsible for reviewing and assessing the adequacy of the charter by which it is governed on an annual basis. Our audit committee has adopted procedures for the treatment of complaints regarding accounting, internal accounting controls or auditing matters, including procedures for the confidential and anonymous submission by our directors, officers, employees and outside consultants of concerns regarding questionable accounting, internal accounting controls or auditing matters. Our audit committee is also responsible for reviewing and, if appropriate, approving related-person transactions. Our board of directors has determined that each of Mr. Booth and Ms. Keenan is an audit committee financial expert under the rules of the Securities and Exchange Commission, and that all of the members of our audit committee are independent under the rules of the Nasdaq Global Select Market. Our audit committee met eight times, and acted by written consent one time, during fiscal 2025.

Nominating and corporate governance committee

During fiscal 2025, our nominating and corporate governance committee was composed of Mr. Concannon, Ms. Detrick, Drs. Taylor and Tookes. Our nominating and corporate governance committee’s responsibilities include providing recommendations to our board of directors regarding nominees for director and membership on the committees of our board of directors, and succession planning for our board of directors. The committee also assists our board of directors in our enterprise risk management by providing recommendations to our board of directors regarding succession plans for our chief executive officer and other senior officers. An additional function of the committee is to develop corporate governance practices for recommendation to our board of directors. The committee is also responsible for reviewing and assessing the adequacy of the charter by which it is governed on an annual basis. Our board of directors has determined that all of the members of our nominating and corporate

TABLE OF CONTENTS

governance committee are independent under the rules of the Nasdaq Global Select Market. Our nominating and corporate governance committee met four times, and acted by written consent one time, during fiscal 2025.

Compensation committee

During fiscal 2025, our compensation committee was composed of Messrs. Avery and Concannon and Ms. Detrick, and Dr. Tookes. Our compensation committee’s responsibilities include providing recommendations to our board of directors regarding the compensation levels of our directors; reviewing and approving, or recommending for approval by our board of directors, the compensation levels of our executive officers; providing recommendations to our board of directors regarding our compensation programs; administering our employee benefit plans, including all incentive compensation plans and equity-based plans; authorizing grants under our stock option plans and other equity-based plans; and authorizing other equity compensation arrangements. The committee is directly responsible for appointing, determining the compensation of, evaluating and, when necessary, terminating our compensation consultant, as well as evaluating the independence of any compensation consultant, legal counsel or other advisor engaged by the committee. The committee is also responsible for reviewing and assessing the adequacy of the charter by which it is governed on an annual basis. Our board of directors has determined that all of the members of our compensation committee are independent under the rules of the Nasdaq Global Select Market. Our compensation committee met eight times, and acted by unanimous written consent five times, during fiscal 2025.

Executive committee

During fiscal 2025, our executive committee was composed of Messrs. Maleh, Booth, Concannon and Ms. Detrick. Our executive committee has delineated authority to act on behalf of our board of directors in situations arising between regular meetings of our board of directors. It is intended that our executive committee will take action only when reasonably necessary to expedite our interests between regularly scheduled board meetings. Our executive committee did not meet during fiscal 2025.

Board leadership structure and role in risk oversight

Mr. Maleh, our president and chief executive officer, serves as the chairman of our board of directors, and Mr. Concannon has served as our independent Lead Director. In light or Mr. Concannon’s retirement from the board of directors, our board elected Christine Detrick as the new independent Lead Director, effective as of the adjournment of the 2026 annual meeting. Our board has determined that this leadership structure is appropriate for the Company because it enables Mr. Maleh to bring to our board of directors valuable leadership experience, a deep and thorough understanding of our business operations and day-to-day management, which facilitates efficient decision-making and effective execution of our strategic initiatives. Our independent Lead Director coordinates all activities of the independent directors, helps facilitate our board’s oversight and shareholder responsibilities, and acts as a liaison between Mr. Maleh and the other independent directors. This structure allows us to benefit from Mr. Maleh’s strategic vision and leadership while maintaining robust independent oversight through our independent Lead Director role and predominantly independent board.

Our management is responsible for the day-to-day management of the risks that we face, while our board of directors, as a whole and through its committees, has responsibility for the oversight of our enterprise risk management. In its risk oversight role, our board of directors is responsible for satisfying itself that our enterprise risk management processes are adequate and functioning as designed. The involvement of our board of directors in risk oversight includes receiving periodic reports from members of senior management and evaluating areas of material risk to us, including operational, financial, legal, regulatory, strategic, cybersecurity and reputational risks. Some risks, such as strategic risks and cybersecurity risks, are typically overseen by the full board. In addition, our board of directors has delegated risk oversight to each of its standing committees within their areas of responsibility. Our compensation committee assists our board of directors in its risk oversight function by overseeing strategies related to our incentive compensation programs and key employee retention. Our audit committee assists our board of directors in its risk oversight function by reviewing our system of disclosure controls and our internal control over

TABLE OF CONTENTS

financial reporting, as well as reviewing and, if appropriate, approving related-person transactions. Our nominating and corporate governance committee assists our board of directors in its risk oversight function by managing risks associated with director candidate selection, governance and succession. Each member of our senior management is initially responsible for assessing and prioritizing the risks that fall under the manager’s area of responsibility and, as a general rule, these risks are discussed with, and then reported to our board of directors or the applicable committee of our board of directors by our general counsel or other appropriate member of our senior leadership team. As part of the process by which our board oversees our enterprise risk management, from time to time our general counsel or other appropriate member of our senior leadership team provides updates regarding enterprise risk to our board of directors in the form of presentations or discussions.

Director candidates and selection process

In evaluating the qualifications of any candidate for director, the nominating and corporate governance committee considers, among other factors, the candidate’s depth of business experience, intelligence, quality of judgment, integrity, familiarity with the legal, regulatory, and business consulting industry, ability to assist in recruiting outside experts and employee consultants, understanding of financial matters, familiarity with the periodic financial reporting process, reputation, level of educational attainment, degree of independence from management, and willingness and ability to serve. The nominating and corporate governance committee also considers the degree to which the candidate’s skills, experience and professional background complement or duplicate those of our existing directors. Among the experiences, attributes, qualities and skills that the nominating and corporate governance committee believes to be necessary for one or more members of our board of directors to possess are familiarity with the segments of the consulting industry in which we compete, substantial experience with the financial reporting process for public companies, and knowledge of the academia of economics. In the case of incumbent directors whose terms are set to expire, the nominating and corporate governance committee also gives consideration to the director’s prior contributions to our board of directors. In evaluating candidates, the nominating and corporate governance committee prefers to retain the flexibility to consider each candidate’s overall mix of qualifications, rather than to specify minimum qualifications that each candidate must possess.

Our nominating and corporate governance committee seeks directors who represent a mix of backgrounds and experiences that will enhance the quality of the discussions and decisions of our board of directors. In the committee’s evaluation of candidates for director, it considers accomplishments, skills and experience, as well as other factors in light of the current composition of our board of directors and our requirements. In selecting candidates to recommend for nomination as a director, the committee abides by our firm-wide non-discrimination policy.

The process followed by our nominating and corporate governance committee to identify and evaluate director candidates includes requests to our current directors and others for candidate recommendations, meetings from time to time to evaluate biographical information and background materials relating to candidates, and interviews of selected candidates by members of the committee and other members of our board of directors. The committee often solicits the opinions of third parties with whom a potential candidate has had a business relationship. Once the committee is satisfied that it has collected sufficient information on which to base a judgment, including vetting procedures such as background checks, the committee votes on the candidates under consideration and recommends to the full board a slate of director candidates for inclusion in our proxy materials.

Our board also actively monitors the tenure and expected service of each director, considering our statement of corporate governance guidelines and our director retirement policy, under which no director may be nominated as a candidate for reelection as part of the slate of directors that we propose, nor may any person be nominated as a candidate for election, after he or she has reached age 72, unless waived by the board of directors.

The nominating and corporate governance committee considers director candidates recommended by shareholders and uses the same process to evaluate candidates, whether the candidates are recommended by shareholders, directors, management or others. The committee has not adopted any particular method that shareholders must follow to make a recommendation. We suggest that shareholders make recommendations by writing to the chair of our nominating and corporate governance committee, in care

TABLE OF CONTENTS

of our offices, with sufficient information about the recommended candidate and his or her work experience, skills, qualifications for director and references to enable the committee to evaluate the candidacy properly. We also suggest that shareholders make their recommendations well in advance of the anticipated mailing date of our next proxy statement to provide our nominating and corporate governance committee an adequate opportunity to complete a thorough evaluation of the candidacy, including personal interviews. We remind shareholders of the separate requirements set forth in our by-laws for nominating individuals to serve as directors, which are discussed in this proxy statement under the heading “Shareholder Proposals” below.

Communications with our board of directors

Our board of directors has established the following process for shareholders to communicate with it, and this process has been approved by a majority of our independent directors. Shareholders wishing to communicate with our board of directors should send correspondence to the attention of Chairman of the Board, CRA International, Inc., 200 Clarendon Street, T-9, Boston, Massachusetts 02116. The correspondence should include satisfactory evidence that the sender of the communication is one of our shareholders. Satisfactory evidence would include, for example, contemporaneous correspondence from a brokerage firm indicating the identity of the shareholder and the number of our shares held by the shareholder.

Our chairman reviews all correspondence confirmed to be from shareholders and decides whether or not to forward the correspondence, or a summary of it, to our board of directors or a committee of our board of directors. The decision to relay any correspondence to our board of directors or a committee of our board of directors rests entirely within our chairman’s discretion.

Our board of directors believes this process suffices to handle the relatively low volume of communications we have historically received from our shareholders. If the volume of communications increases sufficiently to become burdensome to our chairman, our board of directors may elect to adopt more elaborate screening procedures.

TRANSACTIONS WITH RELATED PERSONS

Review, approval or ratification of transactions with related persons

Under our audit committee’s charter, the committee is responsible for reviewing any proposed related-person transaction, as defined under the rules of the Nasdaq Global Select Market, and, if appropriate, approving the transaction. A copy of our audit committee charter is available through the Investor Relations page of our website at www.crai.com.

We did not engage in any transactions with related persons in fiscal 2025.

TABLE OF CONTENTS

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

At the close of business on April 21, 2026, there were issued and outstanding 6,461,963 shares of our common stock entitled to cast 6,461,963 votes. On April 21, 2026, the closing price of our common stock as reported on the Nasdaq Global Select Market was $156.43 per share.

The following table provides information regarding the beneficial ownership of shares of our common stock as of April 21, 2026 by:

•

each person known to us to be a beneficial owner of more than five percent of our shares of common stock;

•

each of our current directors;

•

each of our director nominees;

•

each of our named executive officers; and

•

all of our current directors and current executive officers as a group.

The persons named in the table below have sole voting and sole dispositive power with respect to the shares listed, except as otherwise indicated. The inclusion of shares in the table below does not constitute an admission of beneficial ownership of such shares. The “Right to acquire” column represents shares of our common stock that may be purchased through the exercise of stock options within 60 days after April 21, 2026. The information in the table is based on information received (including via filings made under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) from or on behalf of the persons named in the table.

	Shares beneficially owned
Name of beneficial owner	Outstanding		Right to acquire		Total		Percent(1)
Principal shareholders(2)
FMR LLC(3)		583,841		—		583,841		9.0%
Neuberger Berman Group LLC(4)		583,280		—		583,280		0.0%
BlackRock, Inc.(5)		501,133		—		501,133		7.8%
Copeland Capital Management, LLC(6)		361,270		—		361,270		5.6%
Directors, director nominees and named executive officers:
Paul Maleh(7)		117,252		31,477		148,729		2.3%
Chad Holmes(8)		46,431		8,501		54,932		*
Jonathan Yellin(9)		15,295		5,222		20,517		*
William Concannon(10)		15,595		—		15,595		*
Thomas Avery(10)		14,339		—		14,339		*
Daniel Mahoney(11)		13,782		—		13,782		*
Richard Booth(10)		8,935		—		8,935		*
Christine Detrick(10)		6,139		—		6,139		*
Alva Taylor(10)		3,383		—		3,383		*
Heather Tookes(10)		2,941		—		2,941		*
Karen Keenan(10)		2,400		—		2,400		*
Eric Nierenberg(12)		—		—		—		*
Brian Langan(13)		—		—		—		*
Directors and executive officers as a group (13 persons)		246,492		45,200		291,692		4.5%

Less than 1%.

(1)

Based on 6,461,963 shares of common stock outstanding at April 21, 2026.

TABLE OF CONTENTS

(2)

In a Schedule 13G/A filed with the SEC on August 12, 2024, The Vanguard Group (“Vanguard”) reported aggregate beneficial ownership of 384,345 shares of common stock, which would constitute approximately 5.49% of all of our shares of common stock. However, in a Schedule 13G/A filed with the SEC on March 26, 2026, Vanguard reported that it beneficially owns 0.0% as of March 13, 2026, following an internal reorganization pursuant to which Vanguard’s beneficial ownership has been disaggregated. In its Schedule 13G/A, Vanguard noted that (i) certain subsidiaries or business divisions of subsidiaries of Vanguard that formerly had, or were deemed to have, beneficial ownership with Vanguard will report beneficial ownership separately (on a disaggregated basis) from Vanguard and (ii) that Vanguard no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by such subsidiaries and/or business divisions. Accordingly, Vanguard is not included among the 5% beneficial owners presented in the table.

(3)

The number of shares of our common stock beneficially owned by FMR LLC is based solely on information in a Schedule 13G/A filed on February 9, 2024 by FMR LLC and Abigail P. Johnson, in which Abigail P. Johnson reported sole voting power over 0 shares, FMR LLC reported sole voting power over 583,541 shares and each of Abigail P. Johnson and FMR LLC reported sole dispositive power over 583,841 shares. The address for each of FMR LLC and Abigail P. Johnson is 245 Summer Street, Boston, Massachusetts 02210.

(4)

The number of shares of our common stock beneficially owned by Neuberger Berman Group LLC, Neuberger Berman Investment Advisers LLC, Neuberger Berman Equity Funds and Neuberger Berman Genesis Fund (collectively the “Neuberger Berman Group”) is based solely on information in a Schedule 13G filed on February 12, 2024 by the Neuberger Berman Group, in which Neuberger Berman Group LLC reported shared voting power over 576,252 shares and shared dispositive power over 583,280 shares; Neuberger Berman Investment Advisers LLC reported shared voting power over 576,132 shares and shared dispositive power over 583,160 shares; and each of Neuberger Berman Equity Funds and Neuberger Berman Genesis Fund reported shared voting power over 389,892 shares and shared dispositive power over 389,892 shares. The address for the Neuberger Berman Group is 1290 Avenue of the Americas, New York, New York 10104.

(5)

The number of shares of our common stock beneficially owned by BlackRock, Inc. is based solely on information in a Schedule 13G/A filed on April 17, 2025 by BlackRock, Inc., in which it reported sole voting power over 493,810 shares and sole dispositive power over 501,133 shares. The address for BlackRock, Inc. is 50 Hudson Yards, New York, New York 10001.

(6)

The number of shares of our common stock beneficially owned by Copeland Capital Management, LLC is based solely on information in a Schedule 13G filed on January 22, 2024 by Copeland Capital Management, LLC, in which it reported sole voting power over 289,168 shares and shared dispositive power over 361,270 shares. The address for Copeland Capital Management, LLC is 161 Washington St, Suite 1325, Conshohocken, Pennsylvania 19428.

(7)

Mr. Maleh is our president, chief executive officer and chairman of the board.

(8)

Mr. Holmes is our executive vice president and chief corporate development officer.

(9)

Mr. Yellin is our executive vice president and general counsel.

(10)

Member of our board of directors.

(11)

Mr. Mahoney was our executive vice president, chief financial officer and treasurer until his departure effective April 2025. Mr. Mahoney’s beneficial ownership of outstanding shares is presented as of his departure date.

(12)

Eric Nierenberg is our executive vice president, chief financial officer and treasurer.

(13)

Brian Langan is our executive vice president and chief strategy and business transformation officer.

TABLE OF CONTENTS

COMPENSATION OF DIRECTORS AND EXECUTIVE OFFICERS

Director compensation

In fiscal 2025, we paid our non-employee directors, who consist of all our directors other than our chief executive officer, an annual fee of $85,000 for their services as directors. We paid an annual fee of $25,000 to the chair of our audit committee, $20,000 to the chair of our compensation committee, $10,000 to the chair of our nominating and corporate governance committee, and $5,000 to each non-employee director who serves as a member, but not the chair, of any committee for service on each committee above one. We also paid an annual fee of $30,000 to our lead director. In addition, each independent director serving on a committee receives an additional amount equal to $1,500 for each committee meeting attended by such director after the eighth meeting of such committee in a calendar year. In fiscal 2025, none of the committees met more than eight times and, accordingly, no non-employee director received such additional amount. Our board of directors on a regular basis reviews the competitiveness and appropriateness of its director compensation program to ensure that it is aligned with current leading practices and within competitive pay levels. Directors who are employees do not receive separate fees for their service as directors. All of the payments described in this paragraph are made in cash.

Under the terms of our 2006 equity incentive plan (as amended, the “amended and restated 2006 equity incentive plan”), each director who is not employed by, and does not provide independent contractor services as a consultant or advisor to, us or our subsidiaries receives the automatic restricted stock awards described below. We refer to these directors as our “non-employee directors.” Currently, other than Mr. Maleh, all of our directors are non-employee directors. In fiscal 2025, each non-employee director who was reelected or elected as a director at, or whose term as a director continued after the annual meeting of our shareholders, received on the date of the annual meeting of shareholders in 2025, a restricted stock award, vesting in four equal annual installments beginning on the first anniversary of the date of grant, valued at $125,000 based on the closing price of our common stock as of the date of the meeting. Under our amended and restated 2006 equity incentive plan, the value of these automatic grants of restricted stock awards may be changed by our board of directors.

In fiscal 2025, we awarded the following grants to our non-employee directors in accordance with the terms of our amended and restated 2006 equity incentive plan. In connection with the annual meeting of our shareholders held on July 17, 2025, each of Drs. Tookes and Taylor, Messrs. Avery, Booth and Concannon and Mses. Detrick and Keenan received a restricted stock award of 696 shares of our common stock. Our amended and restated 2006 equity incentive plan has an annual limit of 150,000 on the number of shares that may be granted to a single recipient thereunder in a calendar year.

The following table provides information regarding the compensation earned by our non-employee directors in fiscal 2025.

TABLE OF CONTENTS

Non-Employee Director Compensation Table for Fiscal 2025

Name	Fees Earned or Paid in Cash ($)(1)		Stock Awards ($)(2)(3)(4)(5)		Total ($)
Thomas Avery		85,000		124,939		209,939
Richard Booth		110,000		124,939		234,939
William Concannon		125,000		124,939		249,939
Christine Detrick		100,000		124,939		224,939
Karen Keenan		85,000		124,939		209,939
Alva Taylor		90,000		124,939		214,939
Heather Tookes		105,000		124,939		229,939

(1)

Includes annual retainer and cash fees for committee service.

(2)

These grant date fair values were computed in accordance with Financial Accounting Standards Board Accounting Standards Codification Topic 718, “Compensation—Stock Compensation” (“ASC Topic 718”), excluding the effect of estimated forfeitures, based on the closing market price of our common stock on the date of grant. Additional details on accounting for share-based compensation can be found in note 1, “Summary of Significant Accounting Policies—Share-Based Compensation,” and note 9, “Share-Based Compensation,” to our consolidated financial statements in our annual report on Form 10-K filed with the Securities and Exchange Commission on February 26, 2026.

(3)

Amount reflects the grant date fair value of a restricted stock award made on July 17, 2025, in the case of each non-employee director, in each case under the amended and restated 2006 equity incentive plan.

(4)

As of January 3, 2026, each non-employee director held the number of outstanding unvested shares of restricted stock set forth in the table below.

Name	Shares (#)
Thomas Avery		1,986
Richard Booth		1,986
William Concannon		1,986
Christine Detrick		1,986
Karen Keenan		1,974
Alva Taylor		1,966
Heather Tookes		1,936

(5)

Dividends declared with respect to shares of restricted stock granted to our non-employee directors under our amended and restated 2006 equity incentive plan after July 11, 2018 are not paid until the underlying shares of restricted stock become vested. These dividends are, and have been, factored into the grant date fair values reported for the shares of restricted stock on which they are paid.

Director stock ownership guidelines

The current policy of our board of directors is that our non-employee directors should acquire and obtain shares of our common stock (whether or not vested) with an aggregate value equal to at least 300% of the director’s annual fee ($85,000 in fiscal 2025) for serving on our board of directors. If a non-employee director has not achieved, or is not maintaining this threshold, the director is required to hold 50% of the total shares of our common stock received by him or her upon the vesting of shares of restricted stock, net of any shares sold to cover tax withholding. All of our directors currently meet our stock ownership guidelines.

Compensation committee interlocks and insider participation

During fiscal 2025, the members who served on our compensation committee were Messrs. Avery and Concannon, Dr. Tookes and Ms. Detrick. None of these members was one of our officers or employees

TABLE OF CONTENTS

during fiscal 2025, and none of these members is one of our former officers. None of these members had any relationship requiring disclosure under Item 404 of Regulation S-K. None of our executive officers serves (or served during fiscal 2025) on the board of directors or compensation committee of an entity that has one or more executive officers serving (or who served during fiscal 2025) on our board of directors or compensation committee.

Compensation discussion and analysis

This compensation discussion and analysis provides a detailed description of our executive compensation objectives, practices and programs, as well as the means by which our compensation committee determines executive compensation under those programs. This compensation discussion and analysis focuses on the compensation of our executive officers for fiscal 2025, who were:

•

our president, chief executive officer and chairman of the board, Paul Maleh;

•

our executive vice president, chief financial officer and treasurer, Eric Nierenberg, effective August 2025;

•

our executive vice president, chief financial officer and treasurer, Daniel Mahoney, until his resignation effective April 2025;

•

our executive vice president and chief corporate development officer, Chad Holmes, who additionally assumed the role of interim chief financial officer and treasurer from April 2025 to August 2025;

•

our executive vice president and general counsel, Jonathan Yellin; and

•

our executive vice president and chief strategy and business transformation officer, Brian Langan, effective August 2025.

These executive officers are sometimes referred to as our “named executive officers.”

As used below, the terms “senior corporate leaders,” “practice leaders” and “key revenue generators” refer to the following groups of our employees:

•

senior corporate leaders: our executive officers and other senior-level corporate leaders;

•

practice leaders: our senior employee consultants who lead our practice groups; and

•

key revenue generators: our senior and other employee consultants who generate a high level of revenue for us.

Executive summary

Executive officers

We seek to align the compensation we pay our executive officers with the interests of our shareholders.

Our executive officers’ total compensation each fiscal year is generally comprised of a mix of base salary and a much larger portion of variable at-risk compensation consisting of annual incentive cash bonuses, long-term incentive equity awards and, in some cases, long-term incentive cash awards. This mix of fixed and variable at-risk compensation is designed to create competitive compensation packages that reward our executive officers for achieving our long-term and short-term business objectives, including increasing our growth, profitability and shareholder value, without encouraging unnecessary or excessive risk-taking.

Our LTIP and amended and restated 2006 equity incentive plan

We believe that the equity and cash awards granted under our long-term incentive program, or “LTIP,” are the foundation of our overall pay-for-performance compensation program for our senior corporate leaders, practice leaders and other key revenue generators. These awards serve to motivate high levels of performance, recognize these employees’ contributions to our success, and encourage them to support our long-term growth and profitability, thereby aligning their interests with the interests of our shareholders. We

TABLE OF CONTENTS

conduct our business in a very competitive environment. In order to remain competitive, we must be able to recruit and employ top-flight corporate officers and employee consultants who have abundant talent, demonstrated skills and experience, and, as to employee consultants, the ability to become key revenue generators for us. In addition, we must be able to retain our senior corporate leaders, practice leaders and other key revenue generators. We believe that the awards granted under the LTIP are vital parts of the compensation that we must provide in order to achieve those goals.

Although the LTIP has historically been focused on equity awards, and the executive officers’ entire LTIP is in equity, constraints on the number of shares available under our amended and restated 2006 equity incentive plan resulted in cash awards playing a more prominent role in the LTIP for the senior leaders consisting of our group and practice leaders. In this regard, while seeking to continue to align our group and practice leaders’ compensation with our performance, growth and profitability, our compensation committee split their LTIP compensation between restricted stock units and LTIP-based cash awards, 30% and 70%, respectively. Our key revenue generators received only LTIP cash awards for the past several fiscal years, as well as in fiscal 2025, and will likely continue to receive only LTIP cash awards for the foreseeable future. Our compensation committee continues to review the feasibility of this plan.

Statement of Shares issued under the French Sub-plan pursuant to Section L. 225-197-4 of the French Commercial Code

Our French Sub-plan included in the amended and restated 2006 equity incentive plan requires us to report a statement of shares issued under the French Sub-plan at each annual shareholder meeting. As of April 21, 2026, we have not issued any shares of our common stock under the French Sub-plan.

Compensation program highlights

The table below discusses the material features of our compensation programs.

Compensation Program Highlights
Practice			Highlights
Pay for Performance			• Annual Incentive Cash Bonuses. The annual incentive cash bonuses our executive officers are eligible to receive are tied to the achievement of objective financial goals and individual strategic goals tailored to the executive officer.
			In fiscal 2025, the target payments of annual incentive cash bonuses constituted over 48% of the target cash compensation of our executive officers.(1)
			• Performance-Based LTIP Awards. The equity and cash awards granted under our LTIP include performance-vesting restricted stock units (“PRSUs”) and performance-based cash awards, with vesting tied to the achievement of objective financial goals over one or more fiscal years.
			• NEO Salary. Our performance is one of the primary factors considered by our compensation committee in determining the salaries of our executive officers, including our chief executive officer.
			• Risk Mitigation. To further ensure that payment under our executive compensation packages is commensurate with our performance, these packages have the features discussed in the “Risk Mitigation” section below.

(1)

Target cash compensation includes salary and target annual incentive cash bonuses for 2025 fiscal year performance.

TABLE OF CONTENTS

Compensation Program Highlights
Practice			Highlights
Use of Variable, At-Risk Compensation			• The compensation packages granted to our executive officers include a significant percentage of variable at-risk compensation, including equity awards, the value of which after granting fluctuates with the performance of our common stock, and cash and equity awards with performance objectives that are tied to our performance.
			In fiscal 2025, variable, at-risk compensation(2) comprised approximately 69% of the target total compensation of our executive officers.(3)
Retention			• The stock options, time-vesting restricted stock units (“RSUs”), and PRSUs granted under our LTIP to our named executive officers vest over at least 4 years, with the first tranche vesting no earlier than the first anniversary of the date of grant.
			• Minimum First-Year Vesting Tranche. All awards under our amended and restated 2006 equity incentive plan are granted with a minimum one-year vesting period, subject to a carve out for up to 5% of the shares issuable under the plan.
			• Dividends. The dividend equivalent rights that accrue with respect to the RSUs and PRSUs granted under our amended and restated 2006 equity incentive plan are subject to vesting on the same terms as the underlying award, and thus cannot be paid or otherwise settled until the underlying award has vested. The plan prohibits the payment of dividends or the accruing of dividend equivalent rights on stock options and stock appreciation rights granted under the plan, and prohibits the payment of dividends, and the settlement of dividend equivalent rights accruing, on unvested full-share awards granted under the plan after July 11, 2018, all as further described below under the heading “Dividends and dividend equivalent rights.”
Shareholder Alignment			• Annual Incentive Cash Bonuses. The fiscal 2025 annual incentive cash bonuses were tied to the achievement of equally weighted net revenue and profitability goals, motivating both top-line and bottom-line growth. For the chief executive officer, chief financial officer, chief corporate development officer, chief strategy and transformation officer and general counsel, the proportions of the target annual incentive bonus tied to these goals were 70%, 50%, 50%, 50% and 50%, respectively.
			• LTIP Equity Awards. The awards that may be granted under our LTIP include equity awards that gain value only as our stock price increases after the date of grant. The grants include PRSUs that are based on revenue growth and profitability measured over a performance period of at least one year. These awards further reinforce our focus on top-line and bottom-line growth.

(2)

Variable, at-risk compensation includes annual incentive cash bonuses for 2025 fiscal year performance, and all LTIP equity awards, measured at target.

(3)

Target total compensation includes target cash compensation as described in footnote 1 above, as well as all LTIP equity awards, measured at target.

TABLE OF CONTENTS

Compensation Program Highlights
Practice			Highlights
Risk Mitigation			• Mix of Compensation. In fiscal 2025, our executive officer compensation contained a mix of salary, annual incentive cash bonuses and long-term incentive equity compensation designed to keep our executive officers motivated without encouraging unnecessary or excessive risk-taking.
			• Performance Award Caps/Committee Discretion. The annual incentive cash bonuses that our executive officers were eligible to receive for fiscal 2025 were subject to maximum payment amounts. The payouts are subject to the discretion of our compensation committee, which can reduce or eliminate the amount paid regardless of performance achieved. These factors mitigate the risk of payments that are not commensurate with our actual performance.
			• Ownership Guidelines. We have ownership requirements for equity awards granted to our executive officers under our LTIP described in the “Ownership Guidelines” section below, which align our executive officers’ long-term financial interests with those of our shareholders.
			• Independent Compensation Consultant. Our compensation committee can seek, and has sought and received, advice regarding the structuring of our compensation programs from an independent compensation consultant.
			• Clawback Policy. We have adopted the compensation recovery policy discussed in the section “Clawback Policy” below.
No Derivatives, Hedging, Short Sales; Limited Pledging			• Our trading policy prohibits transactions in derivatives, hedging or short sales of our common stock.
			• Our trading policy prohibits pledging our common stock without the approval of our chief executive officer or our general counsel.
Acceleration Following Change in Control			• Cash Plan Awards. The annual incentive cash bonuses our executive officers are eligible to receive under our cash incentive plan are accelerated in connection with a change in control only if the awards are neither assumed nor substituted for by the acquirer.
			• Equity Plan Awards. There is no automatic acceleration of equity awards under our amended and restated 2006 equity incentive plan, or under our form agreements for these awards, in connection with a change in control. Acceleration in connection with a change in control of assumed or substituted for equity awards granted under our amended and restated 2006 equity incentive plan is limited to double-trigger acceleration. Acceleration in connection with a change in control of performance awards that are neither assumed nor substituted for is limited to acceleration based on actual performance that is prorated for the portion of the performance period that has been completed. In March 2020 and August 2025, as applicable, we entered into severance agreements with each of our named executive officers, which provide for the acceleration of certain equity awards held by the applicable named executive officer upon termination of his employment by the Company without “cause” or by the executive officer for “good reason” within 12 months

TABLE OF CONTENTS

Compensation Program Highlights
Practice			Highlights
			following a change in control, as described in this proxy statement under the heading “Compensation of Directors and Executive Officers—Executive compensation—Potential payments upon termination or change in control” below.
Clawback Policy			• In response to Nasdaq Global Select Market and SEC rules, our board of directors adopted a policy for the recovery of erroneously awarded compensation, which enables it to seek recoupment of annual or long-term incentive cash or equity compensation (including equity awards granted under our amended and restated 2006 equity incentive plan) from our current or former named executive officers in the event of an accounting restatement due to our material noncompliance with any financial reporting requirement under applicable securities laws (excluding restatements resulting from changes to applicable accounting principles).
Ownership Guidelines			• LTIP Awards. The equity awards granted to our executive officers under our LTIP are subject to ownership thresholds, which are set at 400% of annual base salary for our chief executive officer and 300% of annual base salary for each of our other executive officers.
No NEO Tax Gross Ups			• None of our named executive officers has an agreement that provides for any form of tax gross up.
Limited NEO Perquisites			• Except for modest perquisites, our executive officers receive benefits that are comparable to the benefits provided to our other employees and pay costs and taxes on such perquisites on the same basis as other employees.
NEO Severance Agreements			• Each of our named executive officers has a severance agreement with us that provides severance and other benefits in connection with a termination by us without cause or by the named executive officer for good reason with added benefits if such termination is within 12 months of a change in control.

Consideration of the 2025 say-on-pay vote

At the annual meeting of our shareholders held on July 17, 2025, we held a non-binding, advisory shareholder vote on the compensation of our named executive officers as disclosed in the proxy statement filed in connection with that meeting, commonly referred to as a “say-on-pay” vote. Our shareholders overwhelmingly approved the compensation of our named executive officers, as over 95% of the shares voted at the annual meeting on the say-on-pay resolution (excluding abstentions and broker non-votes) were voted in favor of it.

As we evaluated our compensation practices and policies for and throughout fiscal 2025, our compensation committee was mindful of the strong support our shareholders expressed for our philosophy of aligning the compensation of our executive officers with our interests and the interests of our shareholders. In addition, senior management seeks to engage in conversations with our shareholders throughout the year to ensure that management and the board understand and consider the issues that are important to them. As a result, our compensation committee decided to follow the same general approach to executive officer compensation for fiscal 2025 that it has followed since fiscal 2010.

Our compensation committee will continue to consider the outcome of our say-on-pay votes when making future compensation decisions.

TABLE OF CONTENTS

Compensation objectives

Our growth and long-term success depend upon our ability to attract and retain talented and highly qualified corporate executives and employee consultants. The main objectives of our compensation programs are:

•

to provide competitive compensation packages that enable us to attract, retain and reward talented and highly qualified corporate executives and employee consultants who will contribute or are contributing to our growth and long-term success;

•

to align compensation with the interests of our shareholders, and motivate and reward high levels of performance achieved without taking unnecessary or excessive risks, by linking a substantial portion of compensation to performance; and

•

to recognize and reward the achievement of pre-established objective financial and individual performance goals.

We believe these objectives are furthered by the use of compensation packages that include salary, annual incentive cash compensation, long-term incentive equity and/or cash compensation.

Compensation processes and procedures

Role of our compensation committee and chief executive officer

Our compensation committee is responsible for recommending to our board of directors the compensation philosophy and policies that we should follow, particularly with respect to the compensation of members of our senior management. In addition to and among the other duties set forth in this proxy statement under the heading “Corporate Governance—Compensation committee” above, the committee is responsible for:

•

reviewing and approving, or recommending for approval by our board of directors, the compensation of our executive officers, including our chief executive officer;

•

setting, in consultation with management, as applicable, and, if desired by the committee, our compensation consultant, the corporate and individual performance criteria, performance targets and payment formulas of our executive officers’ cash and equity incentive compensation, and overseeing the evaluation of our executive officers in light of those criteria and targets;

•

administering, reviewing and making recommendations to our board of directors with respect to our employee benefit plans, including our incentive cash compensation plans and our equity-based plans; and

•

evaluating whether or not our compensation practices and policies create unnecessary or excessive risks.

When developing recommendations for the compensation of our executive officers other than our chief executive officer, the committee also takes into account recommendations made by our chief executive officer. Our chief executive officer is not permitted to be present when our compensation committee is deliberating on our chief executive officer’s compensation.

Compensation consultant

Our compensation committee has the authority to engage and receive advice from external compensation consultants, with all fees and expenses paid by us. In fiscal 2025, the committee engaged and received advice from Semler Brossy. Semler Brossy reports directly to the committee and provides services only as directed by the committee. Our compensation committee has reviewed Semler Brossy’s policies regarding independence and conflicts of interest and assessed Semler Brossy’s independence. Based on this review and consideration, the committee has determined that Semler Brossy is independent from us and that the services provided to us by Semler Brossy in fiscal 2025 raised no conflicts of interest.

In recent fiscal years, Semler Brossy has advised our compensation committee regarding executive officer and director compensation levels and trends, including the practices of our peers and other companies,

TABLE OF CONTENTS

and the design of our executive officer and director compensation packages, including with respect to the prevalence and structure of financial-related perquisites. Our compensation committee considered this information when setting our named executive officer compensation packages for fiscal 2025.

Although Semler Brossy does not generally participate in meetings of our compensation committee, Semler Brossy may participate, by invitation, in portions of some of the meetings of our compensation committee, including some of the executive sessions without any members of management present. In addition, the chair of our compensation committee and, with respect to the compensation of our other executive officers, our chief executive officer at the direction of our compensation committee may consult, and in fiscal 2025 did consult, with Semler Brossy outside of these meetings.

Setting executive officer compensation and peer groups

In general, our compensation committee is responsible for reviewing and approving, or recommending for approval by our board of directors, the compensation of our executive officers, including our chief executive officer. In fiscal 2025, the compensation of our executive officers was reviewed and approved by our compensation committee. When developing recommendations for the compensation of our executive officers other than our chief executive officer, our compensation committee also took into account recommendations made by our chief executive officer.

To achieve our executive compensation objectives stated above, our compensation committee does not target any particular benchmarks, and instead strives to make decisions concerning executive compensation that:

•

establish incentives that link executive officer compensation to our financial performance and that motivate our executives to attain annual financial targets and long-term strategic goals;

•

provide total compensation packages that are competitive among our peers that offer consulting services similar to ours;

•

establish personal objectives that link executive officer compensation to the achievement of goals that correlate to our growth and long-term financial success; and

•

otherwise align the interests of our executive officers and our shareholders.

Although we compete with other consulting firms to acquire top talent and strive to attract and retain our key employees, including our executive officers, our compensation committee does not target any explicit compensation positioning relative to our peers. Instead, peer group information is just one of the factors considered by our compensation committee when establishing the appropriate level of compensation for our executive officers, and the appropriate allocation of their compensation among salary, annual incentive, and long-term incentive compensation and between cash and equity compensation. Other factors considered by our compensation committee include the scope of the executive officer’s role, the executive officer’s individual performance and experience, and our performance.

In setting our executive officer compensation in fiscal 2025 and other recent fiscal years, our compensation committee has also considered the analysis provided by Semler Brossy regarding the compensation being paid by a peer group comprised of the following public professional service firms that are in businesses comparable to ours:

•

FTI Consulting, Inc.

•

Huron Consulting Group Inc.

•

ICF International

•

Exponent Inc.

In setting our executive officer compensation in recent fiscal years, our compensation committee also reviewed data provided by Semler Brossy derived from industry surveys of the compensation of executive officers by companies of roughly the same size as us and data regressed to our level of revenue.

TABLE OF CONTENTS

Executive officer compensation in fiscal 2025

The principal components of our executive officer compensation granted in or for our fiscal year ending January 3, 2026, were cash compensation and long-term incentive equity compensation. The cash compensation consisted of base salary and annual incentive cash bonuses that our executive officers were eligible to receive based on our fiscal 2025 performance, as well as individual goals established at the beginning of our fiscal year, under our cash incentive plan. The equity compensation consisted of restricted stock unit awards vesting over four years and performance-vesting restricted stock unit awards based on our fiscal 2025 and fiscal 2026 performance, all of which were granted under our LTIP.

We believe that mixing base salary, annual incentive cash bonuses and long-term incentive equity compensation (with vesting based on time and/or performance) is consistent with our overall compensation philosophy because it rewards performance without encouraging unnecessary or excessive risk-taking, provides competitive compensation packages relative to our peers, aligns the interests of our executive officers and our shareholders, aligns executive compensation with key business priorities, and helps us attract and retain top talent.

Salary

We include base salary in our executive officer compensation packages because we believe it is appropriate for a portion of compensation to be fixed and predictable, and because the use of base salary is consistent with the compensation provided to the similarly situated executives of our peers. Our compensation committee generally fixes the annual base salary of our executive officers at its regularly scheduled meeting in the second fiscal quarter of each year. Each executive officer’s base salary reflects his position, experience, past contributions and potential. Annual changes to an executive officer’s base salary, if any, are based on the committee’s assessment of the individual performance of the executive officer, our overall performance and the performances of our business practices, any changes in the executive officer’s role, general economic conditions (such as inflation), and economic forecasts. In determining the base salaries of our executive officers, the committee is also generally mindful of our overall goal of remaining competitive with our peers and retaining our executive officers.

On May 20, 2025, with respect to Mr. Maleh, Mr. Holmes and Mr. Yellin, and on July 16, 2025, with respect to Dr. Nierenberg and Mr. Langan, our compensation committee determined that annual base salary for our executive officers would be as follows: $900,000 for Mr. Maleh, our president and chief executive officer; $500,000 for Mr. Holmes, our executive vice president and chief corporate development officer; $500,000 for Mr. Yellin, our executive vice president and general counsel; $400,000 for Dr. Nierenberg, our executive vice president, chief financial officer and treasurer; and $400,000 for Mr. Langan, our executive vice president and chief strategy and business transformation officer. Mr. Mahoney, our former executive vice president, chief financial officer and treasurer, had an annual base salary of $500,000, as determined by the compensation committee in April 2024.

In determining each of our executive officers’ annual rate of base salary from its fiscal 2024 level, as applicable, the committee considered several factors, including input provided by Semler Brossy, performance of the Company and individual executive officer performance.

One-time cash award

On July 16, 2025, our compensation committee granted Mr. Holmes a one-time cash appreciation award in the amount of $150,000 for his service as interim chief financial officer and treasurer from April 2025 to August 2025.

Annual incentive cash bonuses

In addition to base salary, the cash compensation of our executive officers for fiscal 2025 included annual incentive cash bonuses that our executive officers were eligible to receive under our cash incentive plan, based on the achievement of performance goals linked to certain performance metrics. The use of these annual incentive cash bonuses permits us to provide our executive officers with motivation to pursue particular objectives in any given year that are consistent with our growth and profitability, as well as the

TABLE OF CONTENTS

overall goals and strategic direction set by our board of directors. These annual incentive cash bonuses also tie compensation to performance, and thus play an important role in our pay-for-performance philosophy.

The importance of this philosophy to us and our compensation committee is demonstrated by the fact that in fiscal 2025 the target payment amounts under these annual incentive cash bonuses constituted 55% of the target cash compensation of our president and chief executive officer, and over 43% of the target cash compensation of our other executive officers (other than Mr. Mahoney, for whom a fiscal 2025 target annual incentive cash bonus was not established due to his resignation effective April 2025).(4)

Performance criteria and targets of fiscal 2025 annual incentive cash bonuses

On May 20, 2025, with respect to Mr. Maleh, Mr. Holmes and Mr. Yellin, and July 16, 2025, with respect to Dr. Nierenberg and Mr. Langan, our compensation committee determined the performance criteria, performance targets and payment formulas of the annual incentive cash bonuses that our executive officers were eligible to receive for fiscal 2025 performance under our cash incentive plan.

The performance criteria underlying these annual incentive cash bonuses were based on our fiscal 2025 consolidated non-GAAP net revenue, our fiscal 2025 “Performance Compensation EBITDA,” and subjective individual performance goals for fiscal 2025.(5)

The net revenue and earnings performance criteria were weighted equally, with each tied to 35% of the target payment amount of the annual incentive cash bonus, in the case of our president and chief executive officer, Mr. Maleh, and to 25% of the target payment amount of the annual incentive cash bonus, in the case of each of our other executive officers. This equal weighting of objective financial performance criteria is designed to motivate our executive officers to consider and improve both our growth and our profitability, thereby aligning their interests with the interests of our shareholders. Semler Brossy advised our compensation committee in recent fiscal years that this weighting was in line with the practices of our peer group. The performance targets established by our compensation committee in May and July 2025, as applicable, for these objective financial performance criteria were $748.7 million for our fiscal 2025 consolidated non-GAAP net revenue and $144.2 million for our fiscal 2025 Performance Compensation EBITDA.

The subjective individual goals were tied to 30%, in the case of our president and chief executive officer, Mr. Maleh, and 50%, in the case of each of our other executive officers, of the target payment amount of the annual incentive cash bonus. The individual component of these bonuses is designed to motivate our executive officers to pursue individual, qualitative and strategic goals consistent with their particular roles. These subjective individual goals were set for our executive officers (other than Mr. Maleh, our president and chief executive officer) by our compensation committee in consultation with our chief executive officer and, for Mr. Maleh, by our compensation committee.

Payment formulas of annual incentive cash bonuses for fiscal 2025 performance

The target payments for the annual incentive cash bonuses that our executive officers were eligible to receive for fiscal 2025 performance were as follows: for Mr. Maleh, $1,100,000 (or approximately 122% of annual base salary); for Mr. Yellin, $400,000 (or approximately 80% of annual base salary); for Mr. Holmes, $475,000 (or approximately 95% of annual base salary); and for each of Dr. Nierenberg and Mr. Langan,

(4)

See footnote 1 for the determination of “target cash compensation.”

(5)

As used here, “Performance Compensation EBITDA” means our consolidated GAAP net income reported in our audited financial statements for fiscal 2025, with the following charges added back: interest expense, net, provision for income taxes, depreciation and amortization, share-based compensation expense, amortization of forgivable loans, and other expense, net, all as additionally adjusted for the further non-GAAP adjustments set forth in the following sentence. The non-GAAP net revenue and Performance Compensation EBITDA metrics used for these annual incentive cash bonuses were also subject to the following additional non-GAAP adjustments: acquisitions, discontinued operations, and extraordinary and special items, each to the extent that they arose during fiscal 2025, and any other adjustments to our publicly reported GAAP results in our earnings releases for fiscal 2025, consistent with past practice.

TABLE OF CONTENTS

$250,000 (or approximately 63% of annual base salary). Mr. Mahoney was not eligible to receive an annual incentive cash bonus for fiscal 2025 due to his resignation effective April 2025.

The amounts to be paid under these annual incentive cash bonuses, which were determined by our compensation committee on May 20, 2025 and July 16, 2025, as applicable, as described under the heading “Amounts paid with respect to fiscal 2025 annual incentive cash bonuses” below, could not exceed a maximum payment amount, mitigating the risk that the incentive cash compensation payable to our executive officers for fiscal 2025 would not be commensurate with our actual performance. These maximum payment amounts, which emphasize the relative importance of the objective financial performance criteria underlying them, were determined as follows: (1) the maximum payment of each component linked to net revenue or earnings performance criteria was equal to twice that component’s target payment, and (2) the maximum payment of any component linked to individual subjective performance goals was 140% of that component’s target payment. The target and maximum amounts payable under these annual incentive cash bonuses are reported under the heading “Estimated Future Payouts Under Non-Equity Incentive Plan Awards” in the “Grants of Plan-Based Awards for Fiscal 2025” table below.

The payment formulas under the components of these annual incentive cash bonuses tied to net revenue and earnings performance criteria increased the payment by 1% of the target payment for each 1% that the achievement of the applicable performance criteria exceeded the applicable performance target (subject to the component’s maximum payment amount), and decreased the payment by 1% of the target payment for each 1% that the achievement of the applicable performance criteria missed the applicable performance target (subject to a floor of zero). Our compensation committee initially adopted this one-to-one so-called “leverage curve” in fiscal 2009 based, in part, on advice from Semler Brossy that less steep leverage curves are more appropriate when performance targets are unpredictable and volatile. Our compensation committee decided to retain this one-to-one leverage curve for the components of the annual incentive cash bonuses that our executive officers were eligible to receive for fiscal 2025 performance tied to objective financial performance criteria based on the same rationale.

The payment formula under the components of these annual incentive cash bonuses tied to individual subjective performance goals provided for a payment based on a tally sheet weighted-average score of the executive officer’s achievement of his individual subjective business goals ranging from one (below expectations) to five (exceeds expectations). For each of Messrs. Maleh, Holmes, Yellin and Langan and Dr. Nierenberg, the formula provided for a payment linearly ranging from (1) 60% to 90% of the target payment, if the applicable executive officer’s individual component weighted-average score ranged from one to two, (2) 90% to 110% of the target payment, if the applicable executive officer’s individual component weighted-average score ranged from two to four, and (3) 110% to the maximum 140% of the target payment, if the applicable executive officer’s individual component weighted-average score ranged from four to five.

Regardless of the amount determined by the payment formula of these annual cash incentive bonuses, our compensation committee retained the ability to reduce or eliminate the amount actually paid in its discretion. This discretion mitigated the risk that the annual incentive cash compensation payable to our executive officers for fiscal 2025 could have been disproportionate to our actual performance. Our compensation committee did not exercise such discretion in fiscal 2025.

Amounts paid with respect to fiscal 2025 annual incentive cash bonuses

On March 2, 2026, our compensation committee determined the amounts to be paid to our executive officers with respect to the annual incentive cash bonuses they were eligible to receive for fiscal 2025 performance. These amounts, which are reported in the “Summary Compensation Table” under the heading “Non-Equity Incentive Plan Compensation” in the “Compensation of Directors and Executive Officers—Executive compensation—Summary compensation” section of this proxy statement below, were determined as follows:

•

Component linked to our net revenue. Our fiscal 2025 consolidated non-GAAP net revenue(6) was approximately $751.6 million, or approximately 0.3% below the adjusted performance target for fiscal 2025 of $754.1 million. The compensation committee adjusted the consolidated non-GAAP net

(6)

See footnote 5 for the determination of non-GAAP net revenue.

TABLE OF CONTENTS

revenue target to take into account the $5.4 million impact of foreign currency adjustments during the period. Accordingly, the amount payable under the payment formula for the net revenue component of our executive officers’ fiscal 2025 annual incentive cash bonuses was the target payment decreased by approximately 0.3% of the target payment.

•

Component linked to Performance Compensation EBITDA. Our fiscal 2025 Performance Compensation EBITDA(7) was approximately $146.3 million, or approximately 0.8% above the adjusted performance target for fiscal 2025 of $145.1 million. The compensation committee adjusted the Performance Compensation EBIDA target to take into account the $0.9 million impact of foreign currency adjustments during the period. Accordingly, the amount payable under the payment formula for the earnings component of our executive officers’ fiscal 2025 annual incentive cash bonuses was the target payment increased by approximately 0.8% of the target payment.

•

Component linked to individual subjective performance goals. Based on the subjective individual performance goal weighted-average scores for each of our executive officers, the amounts payable under the payment formula for the subjective individual performance goal component of our executive officers’ fiscal 2025 annual incentive cash bonuses were determined to be between 90% and 105% of each executive officer’s target, reflecting strong individual performance against the qualitative business objectives established by the compensation committee.

Long-term incentive program

As noted above, we believe that the equity and cash awards granted under our long-term incentive program, or “LTIP,” are the foundation of our overall pay-for-performance compensation program for our senior corporate leaders, practice leaders and other key revenue generators. The LTIP generally serves as a framework for equity awards granted under our amended and restated 2006 equity incentive plan and cash awards, other than the annual incentive cash bonuses granted to our executive officers, granted under our cash incentive plan.

The equity and cash awards comprising the grants made under our LTIP are designed to work together to achieve the program’s primary objectives; namely to:

•

directly align a significant portion of the total compensation of these employees with the delivery of future value to our shareholders;

•

focus our senior corporate leaders, practice leaders and other key revenue generators on performance by directly linking their compensation to the achievement of pre-determined performance goals and shareholder returns;

•

provide a competitive compensation program that has significant retention value; and

•

promote top-line and bottom-line growth.

The equity awards granted under our LTIP further align the interests of our executive officers with the interests of our shareholders because they are held subject to the ownership requirements described in this compensation discussion and analysis under the heading “Ownership guidelines” below.

Long-term incentive program: equity awards

As noted above, our LTIP serves as a framework for the equity compensation we grant to our senior corporate leaders, practice leaders and other key revenue generators under our amended and restated 2006 equity incentive plan.

The equity awards granted to our executive officers in fiscal 2025 consisted of the following mix of equity awards: 40% RSUs and 60% PRSUs. For purposes of these weightings, each share by which an RSU or a PRSU is measured is treated as one share, and it is assumed that the PRSUs’ target performance will be achieved.

(7)

See footnote 5 for the determination of Performance Compensation EBITDA.

TABLE OF CONTENTS

The equity awards available under our LTIP include:

•

RSUs because they directly align the interests of the recipient with the interests of our shareholders due to their value being directly tied to the value of our common stock. In addition, the vesting schedule of at least four years applicable to RSUs granted under our LTIP provides long-term retention value.

•

PRSUs because the value of the award is based on our performance, enabling us to provide longer term compensation that motivates the recipient to increase our profitability, our growth and shareholder value. While our standard LTIP PRSUs typically measure performance over a two-year period based on our average Performance Compensation EBITDA(8) margin (including acquisitions and divestitures) and our consolidated non-GAAP cumulative annual net revenue growth (including acquisitions and divestitures),(9) the amended and restated 2006 equity incentive plan provides flexibility to design performance awards with varying metrics, performance periods and vesting schedules to address specific strategic objectives.

Long-term incentive program: awards for fiscal 2025

On May 20, 2025, with respect to Mr. Maleh, Mr. Holmes and Mr. Yellin, and August 4, 2025, with respect to Dr. Nierenberg and Mr. Langan, our compensation committee granted equity awards, composed of RSUs and PRSUs, as described above, to our executive officers under our LTIP (with the exception of Mr. Mahoney, who resigned effective April 2025). The aggregate grant date fair values of these equity awards (assuming the PRSUs’ target performance will be achieved) are as follows: for Mr. Maleh, $2,100,000; for Mr. Holmes, $400,000; for Mr. Yellin, $425,000; for Dr. Nierenberg, $325,000; and for Mr. Langan, $325,000. The aggregate grant date fair values of this equity compensation represented approximately 41% of our executive officers’ fiscal 2025 target total compensation.(10) In addition, all of this equity compensation, the value of which is tied to the value of our common stock, together with the target payments of the annual incentive cash bonuses that our executive officers were eligible to receive based on fiscal 2025 performance, constituted approximately 69% of our executive officers’ fiscal 2025 target total compensation, demonstrating our commitment to providing executive compensation that aligns the interests of our executive officers with the interests of our shareholders, rewards performance, and provides retention value.

The PRSUs granted to our executive officers under our LTIP in fiscal 2025 are based on the performance over fiscal 2025 and fiscal 2026 of our average Performance Compensation EBITDA(11) margin (including acquisitions and divestitures) and our consolidated non-GAAP cumulative annual net revenue growth (including acquisitions and divestitures).(12) The number of shares of our common stock potentially issuable under each of these PRSUs is based on the outcome of their performance conditions and ranges from a threshold of 52% of the PRSU’s target payment to a maximum of 150% of the PRSU’s target payment. If these PRSUs’ threshold performance level is not achieved over their performance period, no payment will be made under them. When determining these PRSUs’ performance targets, our compensation committee sets goals that it believes will be challenging to achieve, based on a review of our future financial plan and general economic conditions, in order to motivate a high degree of business performance with an emphasis on longer term financial objectives.

The number of shares of our common stock by which RSUs are measured, and the threshold, target and maximum number of shares of our common stock by which PRSUs are measured with respect to the LTIP equity awards granted to our executive officers in fiscal 2025 are set forth under the headings “All Other Stock Awards: Number of Shares of Stock or Units,” and “Estimated Future Payouts Under Equity Incentive Plan Awards,” respectively, in the “Grants of Plan-Based Awards for Fiscal 2025” table below.

(8)

See footnote 5 for the determination of Performance Compensation EBITDA.

(9)

See footnote 5 for the determination of non-GAAP net revenue.

(10)

See footnote 3 for the definition of target total compensation.

(11)

See footnote 5 for the determination of Performance Compensation EBITDA.

(12)

See footnote 5 for the determination of non-GAAP net revenue.

TABLE OF CONTENTS

More complete technical descriptions of our LTIP, amended and restated 2006 equity incentive plan, and cash incentive plan are contained in this proxy statement under the headings “Compensation of Directors and Executive Officers—Executive compensation—Plan-based awards” below.

Dividends and dividend equivalent rights

Dividend equivalent rights accrue with respect to the RSUs and PRSUs granted under our amended and restated 2006 equity incentive plan in the form of additional units, which we refer to as “dividend units.” Dividend units are credited to the RSU or PRSU when the corresponding dividend is paid on our common stock. Generally, the number of dividend units credited to an RSU or PRSU with respect to a dividend is determined by multiplying the per-share amount of the dividend by the number of outstanding units under the RSU or PRSU (using the target number of units if the PRSU’s performance conditions are not determined) as of the dividend’s record date, and then dividing the result by our closing stock price on the date the dividend is paid. Dividend units vest on the same dates and in the same relative proportions as the RSUs or PRSUs on which they accrue, and are forfeited if, when and to the extent the RSUs or PRSUs on which they accrue are forfeited. No dividends or dividend equivalent rights will be paid or accrued on stock options or stock appreciation rights granted under the amended and restated 2006 equity incentive plan. No dividends will be paid with respect to unvested full-share awards granted under the plan after July 11, 2018, including shares of restricted stock. Any dividend equivalent rights that accrue on unvested full-share awards granted under the plan after July 11, 2018, will not be paid or otherwise settled until the full-share award has vested, and will be forfeited if the unvested full-share award is forfeited. To date, our board of directors has determined that all dividend units accruing on RSUs or PRSUs will upon vesting be paid only in cash, and not in shares of our common stock.

Ownership guidelines

The equity awards granted under our LTIP to our executive officers are subject to ownership requirements to further promote the long-term nature of the program. The ownership thresholds are 400% of annual base salary for our chief executive officer and 300% of annual base salary for each of our other executive officers. The awards that count towards these share ownership thresholds are (1) vested stock options granted under the LTIP, (2) shares of our common stock issued pursuant to RSUs granted under the LTIP, (3) shares of our common stock issued pursuant to PRSUs granted under the LTIP, and (4) any shares of our common stock or vested stock options delivered to us to be held for purposes of meeting these ownership guidelines. Until one of our executive officer’s employment with us ends or he is no longer otherwise providing services for us, such executive officer may not exercise any stock option issued under the LTIP or delivered to us to be held for purposes of meeting the ownership guidelines, or sell or transfer any shares of common stock issued with respect to RSUs or PRSUs granted under the LTIP or delivered to us to be held for purposes of meeting the ownership guidelines (except for sales to cover withholding taxes with respect to such issuance). In any event, an executive officer may exercise any vested stock option granted under the LTIP or delivered to us to be held for purposes of meeting the ownership guidelines within one year of such stock option’s expiration date. For purposes of these ownership guidelines, shares of our common stock are valued based on the closing price of our common stock reported on the Nasdaq Global Select Market on the day prior to the applicable exercise, sale, transfer or delivery, and vested stock options are valued based on the Black-Scholes option-pricing model. All of our executive officers (other than Mr. Mahoney, who was noncompliant through his resignation effective April 2025, and Dr. Nierenberg and Mr. Langan, due solely to each of their more recent appointments as a member of senior management) are, and were during fiscal 2025, in compliance with these guidelines.

Policy on insider trading and derivatives, hedging, short sales and pledging

We are committed to promoting high standards of ethical business conduct and compliance with applicable laws, rules and regulations. As part of this commitment, we have an insider trading policy and related procedures governing the purchase, sale and other dispositions of our securities by our directors, officers, employees and consultants. Our insider trading policy prohibits our employees, consultants and non-employee directors from (1) purchasing, selling or otherwise trading in options (including publicly traded options), puts, calls, warrants and other derivatives involving or relating to our common stock, (2) engaging in any hedging activities with respect to our common stock, (3) engaging in short sales or taking equivalent

TABLE OF CONTENTS

positions in our common stock, or (4) holding shares of our common stock in a margin account or, without the express authorization of our chief executive officer or general counsel, pledging shares of our common stock as security. Our insider trading policy does not cover transactions of our securities by the Company itself. We believe our insider trading policy and related procedures are reasonably designed to promote compliance with insider trading laws, rules and regulations, and applicable listing standards. A copy of our insider trading policy is filed as an exhibit to our most recent Annual Report on Form 10-K.

Policies and practices related to the grant of equity awards

Our compensation committee has historically followed a practice of generally making all equity awards to our senior corporate leaders, practice leaders and other key revenue generators on one or two dates each year. In fiscal 2025, the compensation committee made equity awards under our LTIP program on May 20, 2025 to Messrs. Maleh, Holmes and Yellin, and on August 4, 2025 to Dr. Nierenberg and Mr. Langan. The compensation committee does not take material nonpublic information into account when determining the timing and terms of equity awards, including stock options, and the Company does not time the disclosure of material nonpublic information for the purpose of affecting the value of executive compensation. During fiscal 2025, no stock options were granted to the executive officers.

Perquisites and other compensation

Our executive officers have typically received modest perquisites—mainly for parking and reimbursement for certain health and dental premiums and expenses. Except for these perquisites, our executive officers receive benefits that are comparable to the benefits provided to our other employees and pay costs and taxes on such perquisites on the same basis as our other employees. Our executive officers and other employees receive other compensation in the form of contributions to our 401(k) savings and retirement plan (described in this compensation discussion and analysis under the heading “401(k) savings plan” below) and premiums we pay for term life insurance, long-term disability insurance and accidental death and dismemberment insurance for the benefit of these employees. Our compensation committee believes that these modest perquisites and other compensation are consistent with our overall policy of providing competitive compensation designed to attract and retain our executive officers.

Compensation actions taken during 2026

On March 2, 2026, our compensation committee determined the number of shares of our common stock issuable based on the outcome of performance conditions of PRSUs granted on April 29, 2024 to our executive officers under our LTIP. These PRSUs’ performance criteria were based on our fiscal 2024 and fiscal 2025 average Performance Compensation EBITDA margin (including acquisitions and divestitures)(13) and consolidated non-GAAP cumulative annual net revenue growth (including acquisitions and divestitures).(14) The number of shares of our common stock potentially issuable under each of these PRSUs based on the outcome of the PRSU’s performance conditions, or its “performance share number,” ranged from a threshold of 50% of the PRSU’s target payment to a maximum of 150% of the PRSU’s target payment. The threshold, target and maximum performance share numbers under these PRSUs were based on threshold, target and maximum performance of 15%, 17% and 19%, respectively, for our fiscal 2024 and fiscal 2025 Performance Compensation EBITDA margin (including acquisitions and divestitures), and 4%, 8% and 12%, respectively, for our fiscal 2024 and fiscal 2025 consolidated non-GAAP cumulative annual net revenue growth (including acquisitions and divestitures). Based on our consolidated Performance Compensation EBITDA margin (including acquisitions and divestitures) for the performance period of 19.0% and our consolidated non-GAAP cumulative annual net revenue growth (including acquisitions and divestitures) over the performance period of 9.8%, our compensation committee determined that the performance share number payable under each of these PRSUs based on their payment matrix was 124% of the PRSU’s target payment. 50% of each of these performance share numbers vested on March 2, 2026 and were paid in shares of our common stock on that date. The remaining 50% of each of these performance share numbers will vest in two equal annual installments on the third and fourth anniversaries of the grant date. The vesting of any portion of a PRSU’s performance share number is subject to the continued

(13)

See footnote 5 for the determination of Performance Compensation EBITDA.

(14)

See footnote 5 for the determination of non-GAAP net revenue.

TABLE OF CONTENTS

employment of the PRSU’s recipient on the vesting date. Vested portions of a PRSU’s payment share number are payable, at our election, in cash, shares of our common stock granted under our amended and restated 2006 equity incentive plan or a combination of the two.

Clawback policy

The Company’s policy for the recovery of erroneously awarded compensation enables our board of directors to seek recoupment of annual or long-term incentive cash or equity compensation (including equity awards granted under our amended and restated 2006 equity incentive plan and cash awards granted under our cash incentive plan) from our current or former named executive officers in the event of an accounting restatement due to our material noncompliance with any financial reporting requirement under applicable securities laws (excluding restatements resulting from changes to applicable accounting principles). The amount recoverable pursuant to this policy is the additional compensation received by the applicable person as a result of the financial statements initially used to determine his or her compensation differing from the restated form, and applies to compensation received in the three fiscal years preceding the accounting restatement. This policy applies to persons who served or serve as an “officer” as defined in Rule 16a-1(f) under the Exchange Act of 1934. Our chief executive officer and chief financial officer are also subject to Section 304 of the Sarbanes-Oxley Act of 2002, which requires them to reimburse us for certain bonus or other incentive-based or equity-based compensation, and certain profits received on the sale of our securities, when there has been an accounting restatement due to our material noncompliance, resulting from misconduct, with any financial reporting requirement under the securities laws.

Severance arrangements

As described in this proxy statement under the heading “Compensation of Directors and Executive Officers—Executive compensation—Potential payments upon termination or change in control” below, in March 2020 and August 2025, as applicable, our executive officers entered into severance agreements with us providing for certain payments upon termination of an executive officer’s employment by the Company without “cause,” by the executive officer with “good reason,” or in connection with a change in control. An executive officer’s death or disability may trigger acceleration of certain equity awards granted to the executive officer under our amended and restated 2006 equity incentive plan pursuant to the executive officer’s severance agreement or, prior to those agreements, the applicable award agreement. A change in control may also trigger payments to our executive officers under our cash incentive plan. Our executive officers are also subject to certain confidentiality, non-competition and non-solicitation agreements.

401(k) savings plan

Under our 401(k) savings plan, a tax-qualified retirement savings plan, participating employees, including our executive officers, may contribute up to 80% of regular and bonus earnings on a before-tax basis, up to the applicable calendar year limit, which was $23,500 in calendar year 2025, into their 401(k) plan accounts. For calendar year 2025, participants aged 50 and over may also make catch-up contributions of $7,500, and participants aged 60 to 63 may make catch-up contributions of up to $11,250. In addition, under the 401(k) plan, we match an amount equal to fifty cents for each dollar contributed by participating employees on the first 6% of their regular and bonus earnings up to a maximum amount. This maximum matching amount was $10,500 in calendar year 2025. Amounts held in 401(k) plan accounts on behalf of an employee may not be withdrawn prior to the employee’s termination of employment with us, total and permanent disability, or such earlier time as the employee reaches the age of 59 1/2, subject to certain exceptions set forth in the regulations of the Internal Revenue Service. We maintain our 401(k) plan because we wish to encourage our employees to save some percentage of their cash compensation for their retirement. Our 401(k) plan permits employees to make such savings in a manner that is relatively tax efficient.

Policy on deductibility of compensation

In general, Section 162(m) of the Internal Revenue Code prevents us from deducting compensation paid in excess of $1 million to certain of our executive officers, called our “covered officers,” in any fiscal year. Once a person becomes a covered person, he or she stays a covered person for all subsequent fiscal years,

TABLE OF CONTENTS

even if not employed by us. We do not make compensation decisions based on the tax treatment of any particular form of compensation.

Compensation committee report

The compensation committee has reviewed and discussed with management the contents of the compensation discussion and analysis set forth above. Based on this review and discussion, the committee recommended to our board of directors that the above compensation discussion and analysis be included in this proxy statement and incorporated by reference into our annual report on Form 10-K for the fiscal year ended January 3, 2026.

The compensation committee
Heather Tookes, Ph.D. (Chair)
Thomas Avery
William Concannon
Christine Detrick

Compensation policies and practices as they relate to risk management

Our compensation committee has reviewed our compensation programs, discussed the concept of risk as it relates to our compensation programs, and considered various mitigating factors. Based on these reviews and discussions, the committee does not believe that our compensation programs encourage excessive or inappropriate risk-taking. Some of the reasons leading to the committee’s conclusion are as follows:

•

The compensation we pay to our senior corporate leaders, practice leaders and other key revenue generators consists of both fixed and variable components. The fixed portion is designed to provide steady income regardless of our common stock’s performance, so that these employees do not focus solely on our stock performance to the detriment of other important business metrics. The equity and cash compensation paid to our senior corporate leaders, practice leaders and other key revenue generators through our LTIP is designed to reward long-term performance. For example, the RSUs and service-based cash awards granted under our LTIP to our senior corporate leaders (other than our executive officers), practice leaders and other key revenue generators vest in equal annual installments over a period of five years, the RSUs granted to our executive officers vest in equal annual installments over a period of four years, and the performance-based cash awards granted under our LTIP are linked to our performance over periods of at least one year. The proportions of salary, annual incentive cash bonuses, and equity compensation are designed to ensure that our senior corporate leaders, practice leaders and other key revenue generators are properly motivated without being encouraged to take unnecessary or excessive risks.

•

The performance criteria underlying the PRSUs granted under our LTIP to our senior corporate leaders, practice leaders and other key revenue generators are based on performance criteria related to revenue growth and earnings margin, which encourages these employees to focus on growth and efficiency and discourages risk-taking focused on improving only one of these measures. There is no payment under any of these awards if the award’s threshold performance levels are not achieved, and each award contains a pre-determined maximum payment, which mitigates risk by making it less likely that the payout on any given award will not correspond to performance.

•

The financial performance criteria underlying the annual incentive cash bonuses that our executive officers were eligible to receive for fiscal 2025 performance under our cash incentive plan are based on revenue and earnings measures, encouraging our executive officers to focus on growth and efficiency. These awards had pre-determined maximum payouts and used a relatively flat one-to-one leverage curve for adjusting the payments for performance that missed or exceeded the awards’ performance targets, which reduced the risk that payouts under the awards would not correspond to performance. Importantly, our compensation committee reserves the right to exercise its discretion to reduce or eliminate the payment made under any of these awards, regardless of the amount resulting from the award’s payment formula.

•

We have adopted minimum ownership guidelines with respect to equity awards granted to our executive officers under our LTIP, which further motivate our executive officers to consider our

TABLE OF CONTENTS

long-term performance. We have also adopted minimum ownership guidelines with respect to equity awards granted to our non-employee directors.

•

We have adopted a compensation clawback policy, which further mitigates the risk that payment under performance awards will not be aligned with our actual performance.

•

Our compensation committee has generally followed a practice of making all equity awards under our LTIP on one or two dates each year, so the equity component of our compensation program cannot be timed or coordinated with the release of material information. In fiscal 2025, the compensation committee made equity awards under our LTIP program on May 20, 2025, to Messrs. Maleh, Holmes and Yellin, and on August 4, 2025, to Dr. Nierenberg and Mr. Langan. The additional grant date for Dr. Nierenberg and Mr. Langan corresponded with the effective date of each of their appointments in August 2025.

•

The outcome and payments of the annual incentive cash bonuses granted to our executive officers under our cash incentive plan, all other performance-based cash awards granted under our cash incentive plan, and PRSUs granted under our LTIP are certified to, and approved by, our compensation committee.

•

Our compensation committee has from time to time sought and received the advice of a compensation consultant engaged by it regarding certain of our compensation practices and policies and the structure and design of our compensation programs. Our committee determined that this consultant, who provided services only as directed by the committee and had no other relationship with us during fiscal 2025, is independent from us and that the services provided to us by this consultant in fiscal 2025 raised no conflicts of interest.

Executive compensation

Summary compensation

The following table provides a summary of all compensation earned with respect to fiscal 2025 by the following:

•

our president, chief executive officer and chairman of the board, Paul Maleh;

•

executive vice president, chief financial officer and treasurer, Eric Nierenberg;

•

our former executive vice president, chief financial officer and treasurer, Daniel Mahoney;

•

our executive vice president and chief corporate development officer, Chad Holmes;

•

our executive vice president and general counsel, Jonathan Yellin; and

•

our executive vice president and chief strategy and business transformation officer, Brian Langan.

As noted above, these executive officers are sometimes referred to as our “named executive officers.” The compensation received by our named executive officers for or in fiscal 2025 consisted of the following:

•

base salary;

•

non-equity incentive plan awards in the form of annual incentive cash bonuses that our executive officers were eligible to receive for 2025 performance;

•

long-term incentive equity awards in the form of RSUs and PRSUs based on our fiscal 2025 and fiscal 2026 performance granted to our executive officers under our LTIP in 2025; and

•

modest perquisites and other compensation.

Further details regarding this compensation can be found in the “Compensation discussion and analysis” above, and in the further disclosure under the heading “Executive compensation” below.

TABLE OF CONTENTS

Summary Compensation Table

Name and Principal Position	Year		Salary ($)		Bonus ($)		Stock Awards ($)(1)(2)(3)		Non-Equity Incentive Plan Compensation ($)(4)		All Other Compensation ($)(5)(6)		Total ($)
Paul Maleh President, chief executive officer and chairman of the board		2025		900,000		—		2,099,925		1,125,000		31,643		4,156,568
		2024		900,000		—		2,099,941		1,160,000		32,992		4,192,933
		2023		900,000		—		1,599,955		1,055,000		29,238		3,584,193
Eric Nierenberg Executive vice president, chief financial officer and treasurer		2025		341,154(7)		—		325,052		305,224(8)		25,478		996,908
Daniel Mahoney Former executive vice president, chief financial officer and treasurer		2025		153,846		—		—		—		12,154		166,000
		2024		500,000		—		600,089		425,000		29,710		1,554,799
		2023		450,000		—		374,990		380,000		29,724		1,234,714
Chad Holmes Executive vice president and chief corporate development officer		2025		500,000		150,000(9)		400,095		500,000		23,361		1,573,456
		2024		500,000		—		1,775,060		505,000		22,116		2,802,176
		2023		450,000		—		374,990		370,000		21,149		1,216,139
Jonathan Yellin Executive vice president and general counsel		2025		500,000		—		424,958		415,000		23,361		1,363,319
		2024		500,000		—		424,970		430,000		22,116		1,377,086
		2023		450,000		—		324,991		335,000		22,139		1,132,130
Brian Langan Executive vice president and chief strategy and business transformation officer		2025		355,385(10)		—		325,052		370,000(11)		25,179		1,075,616

(1)

Amounts reflect the aggregate grant date fair values of RSUs and PRSUs, as applicable, made in the specified fiscal periods to the applicable named executive officer. Specifically, in fiscal 2023, each named executive officer, with the exception of Dr. Nierenberg and Mr. Langan, was granted, on April 11, 2023, RSUs and PRSUs based on fiscal 2023 and fiscal 2024 performance; in fiscal 2024, each named executive officer, with the exception of Dr. Nierenberg and Mr. Langan, was granted, on April 29, 2024, RSUs and PRSUs based on fiscal 2024 and fiscal 2025 performance; in fiscal 2025, each named executive officer (other than Mr. Mahoney) was granted, on May 20, 2025 or August 4, 2025, as applicable, RSUs and PRSUs based on fiscal 2025 and fiscal 2026 performance. In addition, Mr. Holmes was granted, on April 29, 2024, a supplemental PRSU award (the “Supplemental PRSU Award”) that is subject to vesting based on fiscal 2024 through fiscal 2027 performance. These grant date fair values were computed in accordance with ASC Topic 718, excluding the estimated effect of any forfeitures, based on the closing market price of our common stock on the date of grant. In addition, the grant date fair value of each PRSU was computed based on the probable outcome of its performance conditions. Additional details on our accounting for share-based compensation can be found in note 1, “Summary of Significant Accounting Policies-Share-Based Compensation,” and note 9, “Share-Based Compensation,” to our consolidated financial statements in our annual report on Form 10-K filed with the Securities and Exchange Commission on February 26, 2026.

(2)

The grant date fair values of the PRSUs based on fiscal 2025 and 2026 performance granted in fiscal 2025 to each of our executive officers (other than Mr. Mahoney) under our LTIP, assuming the maximum payment under each award is made, are as follows: for Mr. Maleh, $1,889,933; for Dr. Nierenberg, $292,547; for Mr. Holmes, $360,028; for Mr. Yellin, $254,936; and for Mr. Langan, $292,547. The grant date fair values of the PRSUs based on fiscal 2024 and 2025 performance granted in fiscal 2024 to our executive officers under our LTIP, assuming the maximum payment under each award is made, are as follows: for Mr. Maleh, $1,889,903; for Mr. Holmes, $1,735,098 (inclusive of the Supplemental PRSU Award); and for Mr. Yellin, $382,562. Mr. Mahoney did not receive an award in fiscal 2025, and Mr. Mahoney’s PRSUs granted in fiscal 2024 were forfeited upon his departure from the Company. The grant date fair values of the PRSUs based on fiscal 2023 and 2024 performance granted in fiscal 2023 to our executive officers under our LTIP, assuming the maximum payment under each award is made, are as follows: for Mr. Maleh, $1,439,960; for Mr. Mahoney and Mr. Holmes, $337,437; and for

TABLE OF CONTENTS

Mr. Yellin, $292,439. These grant date fair values were computed in accordance with ASC Topic 718, excluding the estimated effect of any forfeitures, based on the closing market price of our common stock on the date of grant.

(3)

Dividend equivalent rights accrue with respect to RSUs and PRSUs granted under our amended and restated 2006 equity incentive plan in the form of additional units, which we refer to as “dividend units.” Dividend units are credited to the RSU or PRSU when the corresponding dividend is paid on our common stock. Generally, the number of dividend units credited to an RSU or PRSU with respect to a dividend is determined by multiplying the per-share amount of the dividend by the number of outstanding units under the RSU or PRSU (using the target number of units if the PRSU’s performance conditions are not determined) as of the dividend’s record date, and then dividing the result by our closing stock price on the date the dividend is paid. Dividend units vest on the same dates and in the same relative proportions as the RSUs or PRSUs on which they accrue. All dividend units that were credited to RSUs or PRSUs in fiscal 2023, fiscal 2024 and fiscal 2025 will upon vesting be paid in cash. Dividends are, and have been, factored into the grant date fair values reported for the RSUs or PRSUs, and thus dividend units are not reported as all other compensation either when credited or settled.

(4)

The amounts shown represent amounts earned in respect of the annual incentive cash bonuses based on performance measured over the specified fiscal years granted to our named executive officers under our cash incentive plan. The amounts earned on the annual incentive cash bonuses for fiscal 2025 performance were determined by our compensation committee on March 2, 2026.

(5)

For fiscal 2025, the amounts shown represent other compensation in the form of contributions to our 401(k) savings and retirement plan on behalf of each of our named executive officers and premiums we paid for term life insurance, long-term disability insurance and accidental death and dismemberment insurance for the benefit of our named executive officers, as well as the perquisites and other personal benefits described in footnote (6) below.

(6)

For fiscal 2025, the amounts shown for our executive officers include our aggregate incremental cost of the following perquisites and other personal benefits paid to our executive officers: parking, reimbursement for certain health and dental premiums and expenses, supplemental health insurance and certain entertainment-related expenses.

(7)

Amount reflects (i) salary earned by Dr. Nierenberg in his capacity as executive vice president, chief financial officer and treasurer from August 4, 2025 through January 3, 2026 in the amount of $169,231, and (ii) salary earned for services provided to the Company in his prior capacity as vice president from December 29, 2024 through August 3, 2025 in the amount of $171,923.

(8)

Amount reflects (i) the annual incentive cash bonus earned by Dr. Nierenberg in his capacity as executive vice president, chief financial officer and treasurer from August 4, 2025 through January 3, 2026 in the amount of $257,000, and (ii) the cash award granted under our LTIP earned in his prior capacity as vice president from December 29, 2024 through August 3, 2025 in the amount of $48,224.

(9)

Amount reflects one-time cash award in appreciation for Mr. Holmes’ service as interim chief financial officer and treasurer from April 2025 to August 2025.

(10)

Amount reflects (i) salary earned by Mr. Langan in his capacity as executive vice president and chief strategy and business transformation officer from August 4, 2025 through January 3, 2026 in the amount of $169,231, and (ii) salary earned for services provided to the Company in his prior capacity as vice president in the Company’s Competition and Labor & Employment group from December 29, 2024 through August 3, 2025 in the amount of $186,154.

(11)

Amount reflects (i) the annual incentive cash bonus earned by Mr. Langan in his capacity as executive vice president and chief strategy and business transformation officer from August 4, 2025 through January 3, 2026 in the amount of $257,000, and (ii) the cash award granted under our LTIP earned for services provided to the Company in his prior capacity as vice president in the Company’s Competition and Labor & Employment group from December 29, 2024 through August 3, 2025 in the amount of $113,000.

Plan-based awards

The plan-based awards granted to our executive officers (other than Mr. Mahoney) in fiscal 2025 consisted of (1) annual incentive cash bonuses that our executive officers were eligible to receive based on

TABLE OF CONTENTS

fiscal 2025 performance under our cash incentive plan, and (2) RSUs and PRSUs based on fiscal 2025 and fiscal 2026 performance, granted to our executive officers on May 20, 2025 or August 4, 2025, as applicable, under our LTIP and our amended and restated 2006 equity incentive plan. For further analysis of the structure of these annual incentive cash bonuses and the LTIP awards granted in fiscal 2025, see the disclosure under the heading “Compensation of Directors and Executive Officers—Compensation discussion and analysis” above. Our cash incentive plan, the LTIP and our amended and restated 2006 equity incentive plan are described below.

Cash incentive plan

Our cash incentive plan authorizes the grant of long-term and annual performance-based and service-based cash awards to our senior corporate leaders, practice leaders, key revenue generators and other salaried employees.

The plan was initially designed to facilitate the granting of performance-based awards to our named executive officers intended to be “qualified performance-based compensation” within the meaning of Section 162(m) of the Internal Revenue Code. The Tax Cuts and Jobs Act of 2017 eliminated the exclusion for qualified performance-based compensation, except for certain grandfathered awards—generally qualified performance-based compensation granted on or prior to, and not modified after, November 2, 2017.

We currently use our cash incentive plan to grant (1) annual incentive cash bonuses to our executive officers, (2) service-based cash awards and/or performance-based cash awards under our LTIP, and (3) either service-based cash awards and/or performance-based cash awards outside of our LTIP.

A performance-based award granted under the plan is payable only to the extent certain performance targets, based on performance criteria specified by our compensation committee, are achieved in the relevant measurement period. These performance targets can be based on objective financial performance criteria, including, but not limited to, revenue; net revenue; net revenue (excluding the impact of one or more of our subsidiaries, acquisitions, discontinued operations and/or extraordinary or special items as determined by our compensation committee); revenue growth; net revenue growth; net revenue growth (excluding acquisitions and divestitures); earnings before interest, taxes, depreciation and amortization or “EBITDA”; adjusted measures of EBITDA adding back, among other expenses, non-cash expenses selected by our compensation committee, or “Adjusted EBITDA”; Adjusted EBITDA margin; funds from operations; funds from operations per share; operating income (loss); operating income growth; operating cash flow; net income; net income growth; pre- or after-tax income (loss); cash available for distribution; cash available for distribution per share; cash and/or cash equivalents available for operations; net earnings (loss); earnings (loss) per share; earnings per share growth; return on equity; return on assets; share price performance; total shareholder return; total shareholder return growth; economic value added; improvement in cash-flow; and confidential business unit objectives. Any of the foregoing measures may be determined on a GAAP or a non-GAAP basis or on a constant-currency basis, or based on an average over periods of one year or longer, and/or with respect to any organizational level specified by our compensation committee, including, but not limited to, our entire company, any parent of us or any of our subsidiaries, in each case as a whole, or any unit, practice, department, group, line of business, or other business unit, whether or not legally constituted, of our entire company, any parent of us or any of our subsidiaries. These performance targets may also be based on performance criteria in the form of individual or other goals specified by our compensation committee.

Performance-based awards granted under the plan must have a minimum performance period of one fiscal year. The maximum amount payable to any recipient in a given fiscal year under performance-based awards granted under the plan is $8,000,000. This maximum is prorated for recipients who do not participate in the plan for the entire fiscal year.

After the completion of the performance period over which a performance-based award granted under our cash incentive plan is based, our compensation committee reviews our performance and the performance of the award recipient over the performance period, and then determines and certifies in writing the extent to which the recipient has achieved the objective performance criteria applicable to the performance award and the appropriate amount, if any, to be paid to the recipient with respect to the performance award.

Regardless of the amount determined by the payment formula applicable to any performance award, the committee may exercise its discretion, based on whatever criteria it determines appropriate, to reduce or

TABLE OF CONTENTS

eliminate the payment made under the performance-based award compared to the award’s payment formula amount. The criteria used by our compensation committee as the basis for any such exercise of its discretion may, but need not be, set forth in the applicable performance award’s terms and conditions. The payment of any performance-based award under the plan is generally made shortly following the certification with respect to such award mentioned above. Performance-based awards issued under our cash incentive plan are payable in cash, shares of our common stock or any combination of the two at the discretion of our compensation committee. The recipient of a performance-based award may receive payment under the award only if he or she is an employee on the last day of the performance period over which the performance-based award is based unless our compensation committee exercises its discretion to make prorated payments to former or retired employees or to a deceased employee’s estate.

In addition to performance-based awards in the form of annual incentive cash bonuses granted to our executive officers, we may also grant under our cash incentive plan service-based cash awards and other performance-based cash awards, including to our senior corporate leaders, practice leaders and other key revenue generators under our LTIP, which awards are further described under the heading “Plan-based awards—Long-term incentive program” below.

All awards issued under our cash incentive plan with respect to a given fiscal year are subject to recoupment, reimbursement or forfeiture under the plan if our financial statements for that fiscal year are negatively affected by a restatement as a result of errors, omissions or fraud, and as otherwise described under the heading “Compensation of Directors and Executive Officers—Compensation discussion and analysis—Clawback policy” above.

Our cash incentive plan was initially approved by our shareholders in 2007 and was reapproved by our shareholders in 2012 and 2017.

Annual incentive cash bonuses for fiscal 2025

On May 20, 2025 and July 16, 2025, as applicable, our compensation committee determined the performance criteria, performance targets and payment formulas of the annual incentive cash bonuses that each of our executive officers (other than Mr. Mahoney) were eligible to receive for fiscal 2025 performance under our cash incentive plan, which are described above under the heading “Compensation of Directors and Executive Officers—Compensation discussion and analysis—Annual incentive cash bonuses.” The target and maximum amounts payable under these annual incentive cash bonuses are also reported under the heading “Estimated Future Payouts Under Non-Equity Incentive Plan Awards” in the “Grants of Plan-Based Awards for Fiscal 2025” table below. On March 2, 2026, our compensation committee determined the amounts to be paid in respect of these annual incentive cash bonuses, as further described above under the heading “Compensation of Directors and Executive Officers—Compensation discussion and analysis—Annual incentive cash bonuses—Amounts paid with respect to fiscal 2025 annual incentive cash bonuses.” These amounts are also reported in the “Summary Compensation Table” above under the heading “Non-Equity Incentive Plan Compensation.”

Long-term incentive program

Our long-term incentive program, or “LTIP,” which was initially adopted by our compensation committee in fiscal 2009, generally serves as a framework for equity awards granted under our amended and restated 2006 equity incentive plan and cash awards, other than the annual incentive cash bonuses granted to our executive officers, granted under our cash incentive plan. As noted above, we believe that the equity and cash awards granted under our LTIP are the foundation of our overall pay-for-performance compensation program for our senior corporate leaders, practice leaders and other key revenue generators. The LTIP is further described under the heading “Compensation discussion and analysis—Executive officer compensation in fiscal 2025—Long-term incentive program” above.

The equity awards granted under our LTIP consist of time-vesting restricted stock units (“RSUs”), performance-vesting restricted stock units (“PRSUs”) and stock options granted under our amended and restated 2006 equity incentive plan. In recent fiscal years, certain recipients have received LTIP awards consisting of RSUs and performance-based cash awards, solely performance-based cash awards, or a combination of service-based and performance-based cash awards.

TABLE OF CONTENTS

Below is a description of the equity awards granted under our LTIP:

•

RSUs. RSUs granted under the LTIP vest over a period of four years, in the case of our named executive officers, and five years, in the case of our other senior corporate leaders, practice leaders and other key revenue generators, in equal annual installments, beginning on the first anniversary of the date of grant. Vested RSUs are payable, at our election, in cash, shares of our common stock or any combination of the two.

•

PRSUs. PRSUs are payable based on the extent that certain performance targets are achieved over a performance period of at least one fiscal year. Each PRSU typically has a threshold, target and maximum performance level and payment amount, though the specific structure may vary based on the objectives being measured. If a PRSU’s threshold performance level is not achieved over the PRSU’s performance period, no payment is made under the PRSU. The performance criteria for PRSUs are designed to align with our business objectives and may include metrics such as revenue growth, average earnings margin and other specific strategic initiatives determined by our compensation committee such as talent acquisition and development. Generally, the vesting under a PRSU is delayed until our compensation committee determines that the PRSU’s performance conditions have been satisfied. Once the performance conditions have been determined to be satisfied, the PRSUs generally vest as to 50% on the date of such determination and in two equal annual installments thereafter, with various vesting schedules possible depending on the nature and timeframe of the performance objectives. We often refer to the number of shares of our common stock potentially issuable under the PRSU based on the outcome of its performance conditions as its “performance share number.” The vesting of any portion of a PRSU’s performance share number is subject to the continued employment of the PRSU’s recipient on the vesting date. Vested portions of a PRSU’s performance share number are payable, at our election, in cash, shares of our common stock or a combination of the two.

•

Stock options. Stock options granted under the LTIP vest over a period of four years in equal annual installments, beginning on the first anniversary of the date of grant, and have a ten-year term, if granted after July 12, 2017, and a seven-year term, if granted before that date. The stock options are granted with an exercise price equal to the fair market value of our common stock on the date of grant and may have their exercise prices reduced only with the approval of our shareholders.

The cash awards granted under our LTIP consist of service cash awards and performance cash awards, which have the following features:

•

Service cash awards. The service-based awards granted under our LTIP provide for the payment of a fixed amount of cash, vesting in five equal annual installments measured from the date of grant.

•

Performance cash awards. The performance-based awards granted under our LTIP provide for a cash payment based on a fixed target amount and the outcome of performance conditions measured over a performance period of at least one year. With the exception of our Canadian employees who are subject to a three-year vesting schedule, the amount payable under these performance-based awards based on the outcome of their performance conditions additionally vests in five equal annual installments, beginning on the first anniversary of the date of grant, except that all vesting is delayed until the outcome of the award’s performance conditions has been determined by our compensation committee.

All stock options and shares of common stock issued pursuant to the vesting of RSUs and PRSUs granted under our LTIP to our executive officers are held subject to our ownership guidelines described above in this proxy statement under the heading “Compensation of Directors and Executive Officers—Compensation discussion and analysis—Ownership guidelines.”

LTIP awards granted in fiscal 2025

On May 20, 2025 and August 4, 2025, as applicable, our compensation committee granted equity awards under our LTIP to each of our executive officers (other than Mr. Mahoney) as further described above under the heading “Compensation discussion and analysis—Executive officer compensation in fiscal 2025—Long-term incentive equity compensation: awards for fiscal 2025.” The number of shares of our

TABLE OF CONTENTS

common stock by which these RSUs are measured, and the threshold, target and maximum number of shares of our common stock by which these PRSUs are measured, are also set forth under the headings “All Other Stock Awards: Number of Shares of Stock or Units,” and “Estimated Future Payouts Under Equity Incentive Plan Awards,” respectively, in the “Grants of Plan-Based Awards for Fiscal 2025” table below.

Amended and restated 2006 equity incentive plan

All equity awards granted to our senior corporate leaders, practice leaders and other key revenue generators, under our LTIP or otherwise, are issued under our amended and restated 2006 equity incentive plan, which is administered by our compensation committee. Our amended and restated 2006 equity incentive plan provides for the following types of equity awards:

•

options to purchase shares of our common stock intended to qualify as “incentive stock options,” as defined in section 422 of the Internal Revenue Code;

•

nonqualified options, which are stock options that do not qualify as incentive stock options;

•

restricted stock awards consisting of shares of our common stock subject to restrictions;

•

restricted stock unit awards consisting of the contractual right to receive shares of our common stock in the future contingent on the completion of service and/or the achievement of performance or other objectives;

•

performance awards consisting of the right to receive payment of cash and/or shares of our common stock on the achievement of pre-determined performance targets; and

•

other stock-based awards in the form of stock purchase rights, stock appreciation rights, unrestricted shares of our common stock, and awards valued in whole or in part by or otherwise based on our common stock.

All of the shares issued under our amended and restated 2006 equity incentive plan or by which awards granted under the plan are measured are shares of our authorized but unissued common stock. The maximum number of shares issuable under the plan is currently 6,149,000, consisting of the following:

•

500,000 shares initially reserved for issuance under our 2006 equity incentive plan;

•

1,000,000 shares reserved for issuance under our 2006 equity incentive plan based on shares that were or became available under the 1998 incentive and nonqualified stock option plan after we adopted our 2006 equity incentive plan on April 21, 2006;

•

210,000 shares approved by our shareholders at the 2008 annual meeting of our shareholders;

•

1,464,000 shares approved by our shareholders at the 2010 annual meeting of our shareholders;

•

1,700,000 shares, consisting of the 2,500,000 shares approved by our shareholders at the 2012 annual meeting of our shareholders reduced by the 800,000 shares cancelled by our board of directors on April 22, 2016, as reported in the current report on Form 8-K that we filed on April 27, 2016;

•

400,000 shares approved by our shareholders at the 2017 annual meeting of our shareholders;

•

375,000 shares approved by our shareholders at the 2018 annual meeting of our shareholders; and

•

500,000 shares approved by our shareholders at the 2023 annual meeting of our shareholders.

The plan adjusts the maximum number of shares issuable under the plan if we effect a capital readjustment or pay a stock dividend without receiving compensation in return. Whenever any outstanding award under the plan expires or terminates other than by exercise or payment in shares of our common stock, the corresponding shares of common stock may again be the subject of plan awards. Each share of our common stock issued pursuant to an award granted on or after April 30, 2010 under the plan, other than a stock option or a stock appreciation right, counts as 1.83 shares against the maximum number of shares issuable under our amended and restated 2006 equity incentive plan, as does any RSU or PRSU granted on or after April 30, 2010 under the plan to the extent that shares of our common stock are used for measurement purposes. The maximum aggregate number of shares of common stock that may be subject to awards granted under our amended and restated 2006 equity incentive plan to a single recipient in any calendar year is 150,000.

TABLE OF CONTENTS

Our 2006 equity incentive plan was first approved by our shareholders in 2006, and our shareholders have agreed to amendments to the plan in 2008, 2010, 2012, 2017, 2018, and, in 2023, an amendment and restatement of the plan.

The grants of plan-based awards table for fiscal 2025

The following table provides further information regarding the grants of plan-based awards described above to our named executive officers during fiscal 2025.

Grants of Plan-Based Awards for Fiscal 2025

Name	Type of Award(1)		Grant Date		Date Compensation Committee Took Action		Estimated Future Payouts Under Non-Equity Incentive Plan Awards				Estimated Future Payouts Under Equity Incentive Plan Awards(2)						All Other Stock Awards: Number of Shares of Stock or Units (#)(2)		Grant Date Fair Value ($)(3)
Name	Type of Award(1)		Grant Date		Date Compensation Committee Took Action		Target ($)		Maximum ($)		Threshold (#)		Target (#)		Maximum (#)				Grant Date Fair Value ($)(3)
Paul Maleh		CIB		5/20/25		—		1,100,000		2,002,000		—		—		—		—		—
		RSU		5/20/25		—		—		—		—		—		—		4,392		839,970
		PRSU		5/20/25		—		—		—		3,425		6,588		9,882		—		1,259,955
Eric Nierenberg		CIB		8/4/25		7/16/25		250,000		425,000		—		—		—		—		—
		RSU		8/4/25		7/16/25		—		—		—		—		—		734		130,021
		PRSU		8/4/25		7/16/25		—		—		572		1,101		1,652		—		195,031
Chad Holmes		CIB		5/20/25		—		475,000		807,500		—		—		—		—		—
		RSU		5/20/25		—		—		—		—		—		—		837		160,076
		PRSU		5/20/25		—		—		—		652		1,255		1,883		—		240,019
Jonathan Yellin		CIB		5/20/25		—		400,000		680,000		—		—		—		—		—
		RSU		5/20/25		—		—		—		—		—		—		889		170,021
		PRSU		5/20/25		—		—		—		693		1,333		2,000		—		254,936
Brian Langan		CIB		8/4/25		7/16/25		250,000		425,000		—		—		—		—		—
		RSU		8/4/25		7/16/25		—		—		—		—		—		734		130,021
		PRSU		8/4/25		7/16/25		—		—		572		1,101		1,652		—		195,031

(1)

For purposes of this column, (a) “CIB” means an annual cash incentive bonus that the applicable executive officer was eligible to receive based on fiscal 2025 performance under our cash incentive plan, (b) “RSU” means a time-vesting restricted stock unit award measured in shares of our common stock granted under our amended and restated 2006 equity incentive plan, and (c) “PRSU” means a performance-vesting restricted stock unit award measured in shares of our common stock granted under our amended and restated 2006 equity incentive plan.

(2)

Dividend equivalent rights accrue with respect to RSUs and PRSUs granted under our amended and restated 2006 equity incentive plan in the form of additional units, which we refer to as “dividend units.” Dividend units are credited to the RSU or PRSU when the corresponding dividend is paid on our common stock. Generally, the number of dividend units credited to an RSU or PRSU with respect to a dividend is determined by multiplying the per share amount of the dividend by the number of outstanding units under the RSU or PRSU (using the target number of units if the PRSU’s performance conditions are not determined) as of the dividend’s record date, and then dividing the result by our closing stock price on the date the dividend is paid. Dividend units vest on the same dates and in the same relative proportions as the RSUs or PRSUs on which they accrue. All dividend units that were credited to RSUs or PRSUs in fiscal 2025 will upon vesting be paid in cash. Dividends are, and have been, factored into the grant date fair values reported for the RSUs or PRSUs, and thus dividend units are not reported in the table above when granted.

TABLE OF CONTENTS

(3)

The grant date fair value was computed in accordance with ASC Topic 718, excluding with respect to RSUs and PRSUs the estimated effect of any forfeitures, based on the closing market price of our common stock on the date of grant. In addition, the grant date fair values of the PRSUs were computed based on the probable outcome of the awards’ performance conditions.

Outstanding equity awards

The following table provides information regarding outstanding equity awards held by our named executive officers on January 3, 2026.

Outstanding Equity Awards at End of Fiscal 2025

	Option Awards										Stock Awards(1)
Name	Type of Awards(2)		Number of Securities Underlying Unexercised Options (#) Exercisable		Number of Securities Underlying Unexercised Options (#) Unexercisable		Option Exercise Price ($)		Option Expiration Date		Number of Shares or Units of Stock That Have Not Vested (#)		Market Value of Shares or Units of Stock That Have Not Vested ($)(7)		Equity Incentive Plan Awards: Number of Unearned Shares, Units or Other Rights That Have Not Vested (#)		Equity Incentive Plan Awards: Market or Payout Value of Unearned Shares, Units or Other Rights That Have Not Vested ($)(15)
Paul Maleh		OPT		16,304		—		44.87		12/18/2027		—		—		—		—
		OPT		15,173		—		47.45		12/6/2028		—		—		—		—
		RSU		—		—		—		—		1,962(3)		393,420		—		—
		RSU		—		—		—		—		3,107(4)		623,016		—		—
		RSU		—		—		—		—		4,328(5)		867,851		—		—
		RSU										4,427(6)		887,702
		PRSU		—		—		—		—		2,825(8)		566,469		—		—
		PRSU		—		—		—		—		5,453(9)		1,093,436		—		—
		PRSU		—		—		—		—		—		—		12,746(10)		2,555,828
		PRSU		—		—		—		—		—		—		9,882(11)		1,981,539
Eric Nierenberg		RSU		—		—		—		—		738(12)		147,984		—		—
		PRSU		—		—		—		—		—		—		1,652(13)		331,159
Chad Holmes		OPT		4,076		—		44.87		12/18/2027		—		—		—		—
		OPT		4,425		—		47.45		12/6/2028		—		—		—		—
		RSU		—		—		—		—		460(3)		92,239		—		—
		RSU		—		—		—		—		728(4)		145,979		—		—
		RSU		—		—		—		—		825(5)		165,429		—		—
		RSU		—		—		—		—		844(6)		169,239
		PRSU		—		—		—		—		662(8)		132,744		—		—
		PRSU		—		—		—		—		1,238(9)		256,265
		PRSU		—		—		—		—		—		—		2,429(10)		487,063
		PRSU		—		—		—		—		—		—		1,883(11)		377,479
		PRSU		—		—		—		—		—		—		9,273(14)		1,859,422
Jonathan Yellin		OPT		2,377		—		44.87		12/18/2027		—		—		—		—
		OPT		2,845		—		47.45		12/6/2028		—		—		—		—
		RSU		—		—		—		—		398(3)		79,807		—		—
		RSU		—		—		—		—		631(4)		126,528		—		—
		RSU		—		—		—		—		875(5)		175,455		—		—
		RSU		—		—		—		—		896(6)		179,666
		PRSU		—		—		—		—		573(8)		114,898
		PRSU		—		—		—		—		1,108(9)		222,176		—		—
		PRSU		—		—		—		—		—		—		2,580(10)		517,342
		PRSU		—		—		—		—		—		—		2,000(11)		401,040
Brian Langan		RSU		—		—		—		—		738(12)		147,984		—		—
		PRSU		—		—		—		—		—		—		1,652(13)		331,159

TABLE OF CONTENTS

(1)

Includes all dividend units that accrued on the RSUs and PRSUs and were unvested as of the end of fiscal 2025. Upon vesting, these dividend units are payable only in cash. Dividend units have been rounded to the nearest whole unit.

(2)

For purposes of this column, (a) “OPT” means a stock option granted under our LTIP and amended and restated 2006 equity incentive plan, (b) “RSU” means a time-vesting restricted stock unit award, measured in shares of our common stock, granted under our LTIP and amended and restated 2006 equity incentive plan, and (c) “PRSU” means a performance-vesting restricted stock unit award granted under our LTIP and amended and restated 2006 equity incentive plan, measured in shares of our common stock, for which the performance conditions were not determined as of the end of fiscal 2025. The vesting of any portion of an RSU or PRSU is subject to the continued employment of the award recipient on the vesting date. Vested portions of any RSU or PRSU are payable, at our election, in cash, shares of our common stock or a combination of the two, except that the corresponding vested dividend units will be paid in cash.

(3)

These RSUs vested on March 10, 2026.

(4)

These RSUs vest in two equal annual installments beginning April 11, 2026.

(5)

These RSUs vest in three equal annual installments beginning on April 29, 2026.

(6)

These RSUs vest in four equal annual installments beginning on May 20, 2026.

(7)

The market values of these unvested RSUs are based on the closing market price of our common stock on January 2, 2026, the last trading date of fiscal 2025, of $200.52.

(8)

Amounts represent the number of PRSUs that have been earned based on our fiscal 2022 and 2023 performance granted on March 10, 2022 to our executive officers. As further described in this proxy statement above under the heading “Compensation of Directors and Executive Officers—Compensation discussion and analysis—Executive officer compensation—Option exercises and vesting of stock,” on March 3, 2024, our compensation committee determined the number of shares of common stock, or “performance share numbers,” that vested for these PRSUs. 50% of each of these performance share numbers vested on the date of that determination, and the remaining 50% of each of these performance share numbers will vest in two equal annual installments on the third and fourth anniversaries of March 10, 2022. Vested portions of these performance share numbers are payable, at our election, in cash, shares of our common stock or a combination of the two, except that the corresponding vested dividend units will be paid in cash.

(9)

Amounts represent the number of PRSUs that have been earned based on our fiscal 2023 and 2024 performance granted on April 11, 2023 to our executive officers. As further described in this proxy statement above under the heading “Compensation of Directors and Executive Officers—Compensation discussion and analysis—Executive officer compensation—Option exercises and vesting of stock,” on March 3, 2025, our compensation committee determined the number of shares of common stock, or “performance share numbers,” that vested for these PRSUs. 50% of each of these performance share numbers vested on the date of that determination, and the remaining 50% of each of these performance share numbers will vest in two equal annual installments on the third and fourth anniversaries of April 11, 2023. Vested portions of these performance share numbers are payable, at our election, in cash, shares of our common stock or a combination of the two, except that the corresponding vested dividend units will be paid in cash.

(10)

Amounts represent the number of PRSUs that have been earned based on our fiscal 2024 and 2025 performance granted on April 29, 2024 to our executive officers. As further described in this proxy statement above under the heading “Compensation of Directors and Executive Officers—Compensation discussion and analysis—Executive officer compensation—Option exercises and vesting of stock,” on March 2, 2026, our compensation committee determined the number of shares of common stock, or “performance share numbers,” that vested for these PRSUs. 50% of each of these performance share numbers vested on the date of that determination, and the remaining 50% of each of these performance share numbers will vest in two equal annual installments on the third and fourth anniversaries of April 29, 2024. Vested portions of these performance share numbers are payable, at our election, in cash, shares of our common stock or a combination of the two, except that the corresponding vested dividend units will be paid in cash.

TABLE OF CONTENTS

(11)

As results as of January 3, 2026 indicate performance at a maximum level, amounts represent the maximum number of shares of our common stock that can be issued under PRSUs based on our fiscal 2025 and 2026 performance granted on May 20, 2025 to Messrs. Maleh, Holmes and Yellin. Our compensation committee will determine the actual number of shares of our common stock potentially issuable in respect of these PRSUs based on the outcome of their performance conditions, or their “performance share numbers,” in the first quarter of fiscal 2027. 50% of each of these performance share numbers will vest on the date of that determination, and the remaining 50% of each of these performance share numbers will vest in two equal annual installments on the third and fourth anniversaries of May 20, 2025. Vested portions of these performance share numbers are payable, at our election, in cash, shares of our common stock or a combination of the two, except that the corresponding vested dividend units will be paid in cash.

(12)

These RSUs vest in four equal annual installments beginning on August 4, 2026.

(13)

As results as of January 3, 2026 indicate performance at a maximum level, amounts represent the maximum number of shares of our common stock that can be issued under PRSUs based on our fiscal 2025 and 2026 performance granted on August 4, 2025 to Dr. Nierenberg and Mr. Langan. Our compensation committee will determine the actual number of shares of our common stock potentially issuable in respect of these PRSUs based on the outcome of their performance conditions, or their “performance share numbers,” in the first quarter of fiscal 2027. 50% of each of these performance share numbers will vest on the date of that determination, and the remaining 50% of each of these performance share numbers will vest in two equal annual installments on the third and fourth anniversaries of August 4, 2025. Vested portions of these performance share numbers are payable, at our election, in cash, shares of our common stock or a combination of the two, except that the corresponding vested dividend units will be paid in cash.

(14)

For purposes of Mr. Holmes’ Supplemental PRSU Award, there is no opportunity to earn a payout above the “target” level; accordingly, the “target” and “maximum” levels are the same. As of January 3, 2026, performance results indicate achievement at or below target level (100%), and therefore the amount shown represents the target number of shares of our common stock that can be issued under Mr. Holmes’ Supplemental PRSU Award granted on April 29, 2024, based on performance in fiscal 2024 through fiscal 2027. Our compensation committee will determine the actual number of shares of our common stock potentially issuable in respect of the Supplemental PRSU Award based on the outcome of its performance conditions, or its “performance share numbers,” in the first quarter of fiscal 2028. 50% of the performance share numbers will vest on the date of that determination, and the remaining 50% will vest on the last day of fiscal 2028, subject in each case to Mr. Holmes’ continued service with the Company through such date. Vested portions of these performance share numbers are payable, at our election, in cash, shares of our common stock or a combination of the two, except that the corresponding vested dividend units will be paid in cash.

(15)

The market values of these PRSUs are based on the closing market price of our common stock on January 2, 2026, the last trading date of fiscal 2025, of $200.52.

Option exercises and vesting of stock

The following table provides information regarding the vesting of our named executive officers’ RSUs and PRSUs during fiscal 2025. No stock options were exercised in fiscal 2025 by our named executive officers. For each named executive officer, the number of shares reported as having vested in fiscal 2025 under the heading “Number of Shares Acquired on Vesting” in the table below consists of (1) shares of our common stock issued under our LTIP and amended and restated 2006 equity incentive plan upon the vesting on March 10, 2025, March 22, 2025, April 11, 2025, and April 29, 2025 of RSUs issued under our LTIP, and (2) shares of our common stock issued under our LTIP and amended and restated 2006 equity incentive plan upon the vesting on March 3, 2025, March 10, 2025 and March 22, 2025 of PRSUs issued under our LTIP.

The shares of common stock issued pursuant to the vesting of the RSUs and PRSUs are subject to our ownership guidelines described in this proxy statement under the heading “Compensation of Directors and Executive Officers—Compensation discussion and analysis—Ownership guidelines” above.

TABLE OF CONTENTS

Stock Vested During Fiscal 2025

	Stock Awards
Name	Number of Shares Acquired on Vesting (#)		Value Realized on Vesting ($)(1)(2)
Paul Maleh		18,883		2,475,517
Daniel Mahoney		3,681		447,427
Chad Holmes		4,358		568,982
Jonathan Yellin		3,714		479,882
Eric Nierenberg		—		—
Brian Langan		—		—

(1)

The value realized on the vesting of shares of restricted stock and the issuance of shares of our common stock with respect to the vesting of RSUs and PRSUs is based on the following closing market prices of our common stock on the respective dates of vesting or, where applicable, the last trading date after the vesting date:

Vesting Date	Closing Market Price ($)
04/29/2025		162.69
04/11/2025		167.90
03/22/2025		180.14
03/10/2025		174.28
03/03/2025		190.45

(2)

The value realized on the vesting of RSUs and PRSUs also includes the amount paid in cash on the date of vesting to the applicable named executive officer in settlement of dividend units that had accrued on the vested RSUs or PRSUs. These dividend units were settled at the per share price of our common stock set forth for the applicable vesting date in note (1) above.

Potential payments upon termination or change in control

The agreements described below provide for payments to the applicable named executive officer, as well as the acceleration of the vesting of certain equity awards held by the executive officer, in the event that the executive officer’s employment with us is terminated in certain circumstances or that we undergo a change in control.

Cash incentive plan

In fiscal 2025, each of our named executive officers (other than Mr. Mahoney) was eligible to receive an annual incentive cash bonus based on fiscal 2025 performance under our cash incentive plan. Under this plan, upon the occurrence of a “change in control,” each of these bonuses is paid out as if the effective date of the change in control were the last day of the applicable performance period and all performance goals had been attained, unless provision is made in connection with the change in control for (1) the assumption of all previously granted awards or (2) the substitution of such performance awards with commensurate new awards covering stock of the successor corporation or its parent or subsidiary.

Under our cash incentive plan, “change in control” means (1) we merge with or into or consolidate with another corporation, unless our outstanding voting securities immediately prior to the change in control continue to represent, either by remaining outstanding or conversion into voting securities of the entity surviving the change in control, at least 50% of our combined voting power or of the combined voting power of the entity surviving the change in control; (2) any person (with standard exceptions) becomes a “beneficial owner” (as such term is defined in Rule 13d-3 promulgated under the Exchange Act), directly or indirectly, of securities representing 50% or more of the combined voting power of our then outstanding securities; or (3) we liquidate or sell substantially all of our assets.

TABLE OF CONTENTS

Stock option agreements

Each of the stock options issued pursuant to our amended and restated 2006 equity incentive plan is subject to a stock option agreement that provides for the full vesting of all unvested stock options subject to the agreement on the applicable named executive officer’s death or termination of providing services for us due to disability (as determined by us in our sole discretion). As of the last business day of fiscal 2025, all of the stock options issued under our amended and restated 2006 equity incentive plan have vested.

Restricted stock and restricted stock unit agreements

As of the last business day of fiscal 2025, each of our named executive officers (other than Mr. Mahoney) held unvested time-vesting restricted stock unit awards, or “RSUs,” issued under our amended and restated 2006 equity incentive plan. Each of these grants is subject to a restricted stock unit agreement. Each of these agreements provides for the full vesting of all unvested RSUs subject to the agreement on the applicable named executive officer’s death or termination of providing services for us due to disability (as determined by us in our sole discretion).

Restricted stock unit for performance agreements

As of the last business day of fiscal 2025, each of our named executive officers (other than Mr. Mahoney) held unvested performance-vesting restricted stock unit awards, or “PRSUs,” issued under our amended and restated 2006 equity incentive plan. Each of these grants is subject to a restricted stock unit for performance agreement that provides for acceleration of vesting on the applicable named executive officer’s death or termination of providing services for us due to disability (as determined by us in our sole discretion). For an award for which the number of shares potentially issuable based on the outcome of the award’s performance conditions, or “performance share number,” has not yet been determined, the amount accelerated is the target performance share number. For an award for which the performance share number has been determined, the amount accelerated is the then unvested portion of the performance share number.

Severance agreements

In March 2020, we engaged our compensation consultant, Semler Brossy, to assist us in reviewing and assessing our executive officer compensation package, including a review of appropriate severance arrangements for our executive officers. After consultation with Semler Brossy, and reviewing a variety of factors, including the scope and nature of severance agreements for the executive officers at our peer companies, we entered into severance agreements with Messrs. Maleh, Mahoney, Holmes and Yellin, and in August 2025, we entered into severance agreements with Dr. Nierenberg and Mr. Langan. The severance agreements provide clarity to our shareholders and executives on the treatment under different termination scenarios, addressing any concerns about how discretion might be applied. These severance agreements provide for certain benefits to the executive officer in a termination event, including in connection with a “change in control.” Pursuant to each executive officer’s severance agreement, if the executive officer’s employment with us is terminated for any reason, the executive officer will be entitled to receive a lump-sum payment equal to the sum of his earned but unpaid base salary through his termination date plus any accrued but unused vacation days, and any other vested benefits that the executive officer may have under our employee benefit plans (collectively referred to as the “Accrued Obligations”).

If the executive officer’s employment is terminated by us without “cause” or by the executive officer for “good reason,” then, in addition to the Accrued Obligations, the executive officer will be entitled to receive the following additional benefits:

•

a cash payment equal to the sum of:

•

in the case of Mr. Maleh, 2.0 times the sum of his annual base salary and target bonus and, in the case of each of Dr. Nierenberg and Messrs. Holmes, Yellin and Langan, one time the sum of the applicable executive officer’s annual base salary and target bonus; plus

•

a pro-rata target annual cash bonus for the portion of the then-current year; and

•

12 months of continued cash payments for COBRA and the employer contribution for group term life insurance.

TABLE OF CONTENTS

In addition, the vesting of any unvested stock options, RSUs or other time-based equity awards held by the executive officer will be fully accelerated. Any PRSUs or other performance-based equity awards held by the executive officer, including Mr. Holmes’ Supplemental PRSU Award, will remain outstanding and will vest based on actual performance following the end of the performance period, provided that (1) any time-based vesting component of such PRSU or performance-based equity award will be treated as fully satisfied upon the expiration of the performance period and (2) any individual performance metrics applicable to the executive officer will be deemed achieved at the target level of performance.

If the executive officer’s employment is terminated by us without “cause” or by the executive officer for “good reason” within 12 months of a “change in control,” then, in addition to the Accrued Obligations, the executive officer will be entitled to receive the following additional benefits:

•

a lump-sum cash payment equal to the sum of:

•

in the case of Mr. Maleh, 2.5 times the sum of his annual base salary and target bonus and, in the case of each of Dr. Nierenberg and Messrs. Holmes, Yellin and Langan, 1.5 times the sum of the applicable executive officer’s annual base salary and target bonus; plus

•

a pro-rata target annual cash bonus for the portion of the then-current year; and

•

a lump-sum cash payment equal to 12 months of COBRA and the employer contribution for group term life insurance.

In addition, with respect to equity awards that are not assumed in connection with a “change in control,” any unvested time-based equity awards held by the executive officer will become fully vested. Any unvested performance-based equity awards will vest based on the level of achievement during the applicable performance period as of the date of the “change in control,” as reasonably determined, with any performance goals adjusted in the board of directors’ good faith discretion to reflect the truncated performance period, except that the number of shares issuable under the award will be adjusted pro rata based on the portion of the performance period that was completed as of the date of the “change in control.”

Upon an executive officer’s death, disability or retirement, each executive officer’s severance agreement provides for full acceleration of the vesting of any unvested time-based equity awards held by the executive officer. Any performance-based equity awards held by the executive officer will remain outstanding and will vest based on actual performance following the end of the performance period, provided that (1) any time-based vesting component of such performance-based equity awards will be treated as fully satisfied upon the expiration of the performance period and (2) any individual performance metrics applicable to the executive officer will be deemed achieved at the target level of performance.

Each of our executive officers (other than Mr. Mahoney) holds unvested RSUs (time-based equity awards) and PRSUs with performance conditions that have not yet been determined (performance-based equity awards) and none of our executive officers holds unvested stock options, which are in each case covered by the applicable officer’s severance agreement.

Daniel Mahoney Resignation and Severance

Mr. Mahoney resigned from his position as executive vice president, chief financial officer and treasurer effective April 11, 2025, pursuant to Section 2(e) of his severance agreement. Mr. Mahoney’s resignation did not constitute a termination by the Company without Cause or a termination by Mr. Mahoney for Good Reason (each as defined in Mr. Mahoney’s severance agreement), and was not in connection with a change in control.

In connection with his resignation, and in accordance with Section 3(c) of his severance agreement, Mr. Mahoney was entitled to receive his accrued obligations, consisting of earned but unpaid base salary through his termination date, accrued but unused vacation, and any other vested benefits under the Company’s employee benefit plans. Mr. Mahoney did not receive any severance payments, post-termination salary continuation, target bonus severance, or continued benefits beyond his accrued obligations, and all unvested equity awards held by Mr. Mahoney were forfeited upon his resignation.

TABLE OF CONTENTS

Hypothetical termination or change in control as of the end of fiscal 2025

The tables below summarize the payments that our named executive officers would receive, as well as the value of the acceleration of the vesting of equity awards held by them, under the agreements described above in connection with certain hypothetical terminations or changes in control as of January 2, 2026, the last business day of fiscal 2025.

Potential Payments Upon Termination By Company Without Cause(1) or by Executive
With Good Reason(2) Not in Connection with a Change in Control as of January 2, 2026

	Salary ($)(3)		Target Incentive Bonus ($)(4)		Cash Management Performance Award ($)(5)		Restricted Stock Units ($)(6)		Performance Restricted Stock Units ($)(7)		Total Payment Upon Termination ($)
Paul Maleh		1,846,535		2,200,000		1,100,000		4,431,893		4,537,367		14,115,795
Eric Nierenberg		387,689		250,000		250,000		147,984		331,159		1,366,832
Chad Holmes		546,535		475,000		475,000		961,894		2,723,964		5,182,393
Jonathan Yellin		546,535		400,000		400,000		898,530		918,382		3,163,447
Brian Langan		401,920		250,000		250,000		147,984		331,159		1,381,062

(1)

“Cause” is defined as: (i) any material breach by the executive of any agreement to which the executive and CRA (or any parent or subsidiary of CRA) are both parties, (ii) any act or omission by the executive that is in material violation of any material policy of CRA, (iii) the conviction of the executive by a court of competent jurisdiction for (or plea by the executive of no contest with respect to) felony criminal conduct, or (iv) any material misconduct or material neglect of duties by the executive in connection with the business or affairs of CRA (or any parent or subsidiary).

(2)

Executive has complied with the “Good Reason Process” (as defined in each severance agreement) following the occurrence of any of the following events without executive’s consent: (i) a material reduction in the executive’s duties, authorities or responsibilities or a requirement that the executive report to anyone other than the Board, in the case of Mr. Maleh, or the President or Chief Executive Officer, in the case of Dr. Nierenberg and Messrs. Holmes, Yellin and Langan; (ii) a reduction in the executive’s annual base salary or annual bonus opportunity (other than an across-the-board reduction of not more than ten percent (10%) applicable to all senior executive officers which occurs prior to a change in control); (iii) a material reduction in executive’s benefits in the aggregate (other than an across-the-board reduction of benefit levels) from those provided to executive; (iv) a relocation of executive’s principal place of employment out of the city of Boston, Massachusetts, in the case of Dr. Nierenberg and Messrs. Maleh, Yellin and Langan, or Chicago, Illinois, in the case of Mr. Holmes; (v) a material breach of any provision of the executive’s severance agreement by CRA; (vi) the failure of CRA to have a successor entity specifically assume the severance agreement within ten (10) business days after a change in control; or (vii) the insolvency of CRA or the filing (by any party, including CRA) of a petition for bankruptcy with respect to the Company, which petition is not dismissed within 60 days.

(3)

Represents a payment equal to two times Mr. Maleh’s base salary and one time the base salary of each of Dr. Nierenberg and Messrs. Holmes, Yellin and Langan paid in accordance with CRA’s payroll practices over a period of 12 months. Also includes $46,535 for each of Dr. Nierenberg and Messrs. Maleh, Holmes, Yellin and Langan, which reflects 12 months of continued cash payments for COBRA and the employer contribution for group term life insurance.

(4)

Represents a payment equal to two times Mr. Maleh’s base target incentive bonus and one time the target incentive bonus of each of Dr. Nierenberg and Messrs. Holmes, Yellin and Langan paid in accordance with CRA’s payroll practices over a period of 12 months.

(5)

Amounts represent target payouts under annual incentive cash bonuses that our named executive officers were eligible to receive for fiscal 2025 performance under our cash incentive plan. The amounts actually to be paid with respect to these bonuses were determined by our compensation committee on March 2, 2026, and are reported above in the “Summary Compensation Table” under the heading “Non-Equity Incentive Plan Compensation.”

TABLE OF CONTENTS

(6)

Amounts represent the value of the full acceleration of vesting of RSUs, and PRSUs for which the performance conditions had been determined prior to the end of fiscal 2025, granted under our amended and restated 2006 equity incentive plan and LTIP and held by the applicable executive officer as of the last business day of fiscal 2025. These unvested RSUs and PRSUs are reported as awards of type “RSU” and “PRSU” in the “Outstanding Equity Awards at End of Fiscal 2025” table above under the heading “Number of Shares or Units of Stock That Have Not Vested.” The value of this acceleration was determined based on the closing market price of our common stock on January 2, 2026, the last business day of fiscal 2025, of $200.52.

(7)

Amounts represent the value of (1) the full acceleration of vesting of PRSUs granted on April 29, 2024 under our amended and restated 2006 equity incentive plan and LTIP and held by the applicable executive officer as of the end of the fiscal 2025 with performance periods consisting of fiscal 2024 and fiscal 2025 (the “2024/2025 PRSUs”), assuming target performance, (2) the full acceleration of vesting of PRSUs granted on May 20, 2025, in the case of Messrs. Maleh, Holmes and Yellin, and on August 4, 2025, in the case of Dr. Nierenberg and Mr. Langan, under our amended and restated 2006 equity incentive plan and LTIP and held by the applicable executive officer as of the end of the fiscal 2025 with performance periods consisting of fiscal 2025 and fiscal 2026 (the “2025/2026 PRSUs”), assuming target performance and (3) with respect to Mr. Holmes, the full acceleration of vesting of his Supplemental PRSU Award, assuming target performance. The PRSUs, including the Supplemental PRSU Award, will remain outstanding and will vest and be settled based on actual performance during the applicable performance period with (x) any time-based vesting that may be applicable in addition to performance-based vesting treated as fully satisfied upon the expiration of the performance period and (y) any individual performance metric applicable to the executive officer deemed achieved at the target level of performance. As a result, the 2024/2025 PRSUs would not settle or vest until the performance determination has been made in early 2026, the 2025/2026 PRSUs would not settle or vest until the performance determination has been made in early 2027, and the Supplemental PRSU Award would not settle or vest until the performance determination has been made in early 2028. The table reflects achievement of the 2024/2025 PRSUs based on target performance as of the termination date; as further described in this proxy statement above under the heading “Compensation of Directors and Executive Officers—Compensation discussion and analysis—Executive officer compensation—Option exercises and vesting of stock,” on March 2, 2026, our compensation committee determined the number of shares of common stock, or “performance share number,” that vested for the 2024/2025 PRSUs. Any PRSU or portion thereof that does not vest based on actual performance during the performance period shall be immediately forfeited and cancelled. The value of this acceleration was determined based on the closing market price of our common stock on January 2, 2026, the last business day of fiscal 2024, of $200.52.

The following table assumes that the hypothetical change in control would be a “change in control” for purposes of our cash incentive plan and severance agreements and that the applicable annual incentive cash bonuses would neither be assumed nor substituted for in the change in control.

Potential Payments Upon Termination Without Cause(1) or Good Reason(2)
Within 12 Months of a Change in Control as of January 2, 2026

	Salary ($)(3)		Target Incentive Bonus ($)(4)		Cash Management Performance Award ($)(5)		Restricted Stock Units ($)(6)		Performance Restricted Stock Units ($)(7)		Total Payment Upon Termination or Change in Control ($)
Paul Maleh		2,296,535		2,750,000		1,100,000		4,431,893		4,537,367		15,115,795
Eric Nierenberg		558,266		375,000		250,000		147,984		331,159		1,662,409
Chad Holmes		796,535		712,500		475,000		961,894		2,723,964		5,669,893
Jonathan Yellin		796,535		600,000		400,000		898,530		918,382		3,613,447
Brian Langan		579,612		375,000		250,000		147,984		331,159		1,683,755

TABLE OF CONTENTS

(1)

(2)

(3)

Represents a lump-sum payment equal to 2.5 times Mr. Maleh’s base salary and 1.5 times the base salary of each of Dr. Nierenberg and Messrs. Holmes, Yellin and Langan. Also includes $45,683, for each of Dr. Nierenberg and Messrs. Maleh, Holmes, Yellin and Langan, which reflects a lump-sum payment equal to 12 months of continued cash payments for COBRA and the employer contribution for group term life insurance.

(4)

Represents a lump-sum payment equal to 2.5 times Mr. Maleh’s base target incentive bonus and 1.5 times the target incentive bonus of each of Dr. Nierenberg and Messrs. Holmes, Yellin and Langan.

(5)

(6)

(7)

TABLE OF CONTENTS

the percentage of the performance period that was completed immediately prior to the assumed effective date of the assumed change in control.

The following table assumes that the hypothetical disability would be a disability for purposes of our stock option agreements, restricted stock agreements, restricted stock unit agreements, restricted stock unit for performance agreements, service cash award agreements, performance cash award agreements and severance agreements.

Potential Payments Upon Termination Upon Death, Disability or Retirement as of January 2, 2026

	Salary ($)		Target Incentive Bonus ($)		Cash Management Performance Award ($)		Stock Options ($)		Restricted Stock Units ($)(1)		Performance Restricted Stock Units ($)(2)		Total Payment Upon Termination Upon Death, Disability or Retirement ($)
Paul Maleh		—		—		—		—		4,431,893		4,537,367		8,969,260
Eric Nierenberg		—		—		—		—		147,984		331,159		479,143
Chad Holmes		—		—		—		—		961,894		2,723,964		3,685,858
Jonathan Yellin		—		—		—		—		898,530		918,382		1,816,912
Brian Langan		—		—		—		—		147,984		331,159		479,143

(1)

(2)

Amounts represent the value of (1) the full acceleration of vesting of the 2024/2025 PRSUs, assuming target performance, (2) the full acceleration of vesting of the 2025/2026 PRSUs, assuming target performance and (3) with respect to Mr. Holmes, the full acceleration of vesting of his Supplemental PRSU Award, assuming target performance. The PRSUs will remain outstanding and will vest and be settled based on actual performance during the applicable performance period with (x) any time-based vesting that may be applicable in addition to performance-based vesting treated as fully satisfied upon the expiration of the performance period and (y) any individual performance metric applicable to the executive officer deemed achieved at the target level of performance. As a result, the 2024/2025 PRSUs would not settle or vest until the performance determination has been made in early 2026 and the Supplemental PRSU Award would not settle or vest until the performance determination has been made in early 2028. The table reflects achievement of the 2023/2024 PRSUs, the 2024/2025 PRSUs and the 2025/2026 PRSUs based on target performance as of the termination date; as further described in this proxy statement above under the heading “Compensation of Directors and Executive Officers—Compensation discussion and analysis—Executive officer compensation—Option exercises and vesting of stock,” on March 2, 2026, our compensation committee determined the number of shares of common stock, or “performance share number,” that vested for the 2024/2025 PRSUs. Any PRSU or portion thereof that does not vest based on actual performance during the performance period shall be immediately forfeited and cancelled.

The value of this acceleration was determined based on the closing market price of our common stock on January 2, 2026, the last business day of fiscal 2025, of $200.52.

TABLE OF CONTENTS

CEO Pay Ratio

As required by Section 953(b) of the Dodd-Frank Wall Street Reform and Consumer Protection Act, and Item 402(u) of Regulation S-K, we are providing the following information about the relationship of the annual total compensation of our “median employee” and the annual total compensation of Mr. Maleh, our president, chief executive officer and chairman of the board, for fiscal 2025.

In accordance with Item 402(u) of Regulation S-K, because there has been no change in our employee population or employee compensation arrangements during our last completed fiscal year that we reasonably believe would result in a significant change to our pay ratio disclosure, we are permitted to utilize the same median employee that we identified in fiscal 2023 to calculate our pay ratio for fiscal year 2025. Because our original median employee is no longer employed by the Company, we are permitted to identify another employee whose compensation is substantially similar to the original median employee, as disclosed in our fiscal 2023 proxy statement and as further described below.

For 2025, our last completed fiscal year:

•

the annual total compensation of Mr. Maleh was $4,156,568; and

•

the annual total compensation of our median employee was $225,864.

Based on the foregoing, for fiscal 2025, the ratio of the annual total compensation of our chief executive officer to the annual total compensation of our median employee, as reasonably estimated in accordance with Item 402(u) of Regulation S-K, was 18 to 1.

When we identified our median employee for fiscal 2023, we used the following methodology and made the following material assumptions, adjustments, and estimates:

•

We identified our employee base as of December 30, 2023, the last day of our 2023 fiscal year. Our employee population as of that date consisted of 1,187 employees, including our chief executive officer. Excluding our chief executive officer, and excluding an additional total of 50 employees located in seven non-U.S. jurisdictions who represented approximately 4.2% of our total employee base of 1,187 employees as of December 30, 2023, the size of our employee base for purposes of determining our median employee was 1,137. The following number of employees in the following non-U.S. jurisdictions were excluded:

Jurisdiction	Headcount
Australia		2
Belgium		26
Brazil		6
Czech Republic		1
France		3
Norway		1
Switzerland		11

•

We identified our median employee using a consistently applied compensation measure of 2023 taxable income, as determined in the applicable jurisdiction. Compensation paid in currencies other than U.S. dollars was converted into U.S. dollars using the following 2023 full-year exchange rates:

•

British pound to U.S. dollar: 1.2437

•

the euro to U.S. dollar: 1.0815

•

the Canadian dollar to U.S. dollar: 0.7411

•

In determining the 2023 taxable income of our full-time and part-time employees who were not employed by us for all of 2023, we annualized their actual taxable income based on the number of days that they were employed by us in 2023. Our employee base for purposes of determining our median employee did not contain any seasonal or temporary employees.

We calculated the annual total compensation of Mr. Maleh and our median employee using the same methodology that we used to calculate the annual total compensation of our named executive officers

TABLE OF CONTENTS

reported in the “Summary Compensation Table,” or SCT, above. As this amount reported for Mr. Maleh includes all of the compensation he earned under non-discriminatory benefit plans in fiscal 2025, the compensation earned by our median employee under non-discriminatory benefit plans in fiscal 2025 was also included in the annual total compensation for our median employee reported above.

Pay Versus Performance Table

As required by Section 953(a) of the Dodd-Frank Wall Street Reform and Consumer Protection Act, and Item 402(v) of Regulation S-K, the following table sets forth additional compensation information of Mr. Maleh, our principal executive officer, or PEO, and our other named executive officers, or Non-PEO NEOs, and Company performance for the fiscal years ended in 2021, 2022, 2023, 2024 and 2025.

Fiscal Year (a)	Summary Compensation Table Total for PEO(1) (b)			Compensation Actually Paid to PEO(1)(2)(3) (c)			Average Summary Compensation Table Total for Non-PEO NEOs(1) (d)			Average Compensation Actually Paid to Non-PEO NEOs(1)(2)(3) (e)			Value of Initial Fixed $100 Investment Based on(4):						Net Income ($ in millions) (h)			Non-GAAP Net Revenue ($ in millions)(5) (i)
Fiscal Year (a)	Summary Compensation Table Total for PEO(1) (b)			Compensation Actually Paid to PEO(1)(2)(3) (c)									Total Shareholder Return (TSR) (f)			Peer Group Total Shareholder Return (g)			Net Income ($ in millions) (h)			Non-GAAP Net Revenue ($ in millions)(5) (i)
2025		$	4,156,568		$	4,843,318		$	1,035,060		$	610,520		$	419.07		$	134.42		$	54.8		$	751.6
2024		$	4,190,131		$	9,414,522		$	1,911,354		$	3,353,505		$	375.29		$	158.19		$	46.7		$	687.4
2023		$	3,584,193		$	1,719,457		$	1,194,327		$	784,896		$	196.45		$	156.21		$	38.5		$	624.0
2022		$	3,794,707		$	6,666,030		$	1,281,503		$	1,891,193		$	239.76		$	138.71		$	43.6		$	590.9
2021		$	3,838,392		$	8,739,743		$	1,169,357		$	2,136,051		$	180.35		$	140.76		$	41.7		$	565.9

(1)

Mr. Maleh has been our PEO for each year presented. For purposes of calculating the average compensation amounts for our non-PEO NEOs, Messrs. Holmes and Yellin were included for each year presented. Mr. Mahoney was included for fiscal years 2021 through 2024 and for a portion of fiscal 2025 through his resignation in April 2025. Dr. Nierenberg and Mr. Langan were included beginning in fiscal 2025 following their appointments as NEOs effective August 2025. Compensation amounts for each non-PEO NEO reflect compensation earned during the applicable fiscal year, including compensation earned for partial-year service.

(2)

The amounts shown for Compensation Actually Paid have been calculated in accordance with Item 402(v) of Regulation S-K and do not reflect compensation actually earned, realized, or received by the Company’s NEOs. These amounts reflect the Summary Compensation Table Total with certain adjustments as described in footnote 3 below.

(3)

Compensation Actually Paid reflects the exclusions and inclusions of certain amounts for the PEO and the Non-PEO NEOs as set forth below. The fair value of stock awards was determined using methodologies and assumptions developed in a manner substantively consistent with those used to determine the grant date fair value of such awards.

	Summary Compensation Table (“SCT”) Total			Less, Value of Stock Awards reported in SCT			Plus, Year- end value of awards granted in fiscal year that are unvested and outstanding			Plus/(Less), Change in fair value of prior year awards that are unvested and outstanding			Plus, Fair market value of awards granted in fiscal year that vested in fiscal year			Less, Change in fair value (from prior year-end) of prior year awards that vested in fiscal year			Less, Prior year- end fair value of awards that failed to vest in fiscal year			Plus, Value of dividends paid on equity awards			Total Adjustments			Compensation Actually Paid
PEO Adjustments		$	4,156,568		$	(2,099,925)		$	2,494,573		$	373,198		$	—		$	(174,589)		$	—		$	93,493		$	686,750		$	4,843,318
Non-PEO NEO Adjustments		$	1,035,060		$	(295,031)		$	362,777		$	(194,901)		$	—		$	(20,309)		$	(286,218)		$	9,144		$	(424,540)		$	610,520

TABLE OF CONTENTS

(4)

The Peer Group Total Shareholder Return, or TSR, set forth in this table utilizes the customized peer group, which we also utilize in the stock performance graph required by Item 201(e) of Regulation S-K included in our Annual Report on Form 10-K for the year ended January 3, 2026. The customized peer group consists of three companies: Exponent Inc., FTI Consulting Inc. and Huron Consulting Group Inc. The comparison assumes $100 was invested for the period starting January 2, 2021, through the end of the listed year in the Company and in the customized peer group, respectively. All dollar values assume reinvestment of the pre-tax value of dividends paid by companies, where applicable, included in the customized peer group. Historical stock performance is not necessarily indicative of future stock performance.

(5)

Non-GAAP net revenue was subject to the following non-GAAP adjustments: acquisitions, discontinued operations, and extraordinary and special items, each to the extent that they arose during fiscal 2021, 2022, 2023, 2024 and 2025 and any other adjustments to our publicly reported GAAP results in our earnings releases for each applicable fiscal year, consistent with past practice.

The charts below display the relationship between the compensation actually paid to our PEO and each of our Non-PEO NEOs and TSR, GAAP Net Income, Non-GAAP Net Revenue, as well as the relationship between our TSR and the TSR of our Peer Group.

TABLE OF CONTENTS

[MISSING IMAGE: bc_capvsnetincome-4c.jpg]

[MISSING IMAGE: bc_capvsnetrevenue-4c.jpg]

TABLE OF CONTENTS

Tabular List of Most Important Financial Performance Measures

The following performance measures reflect the Company’s most important financial performance measures in effect for 2025, for purposes of setting executive compensation as further described and defined in the sections titled “Compensation of Directors and Executive Officers—Compensation discussion and analysis” and “Executive compensation.” The measures in this table are not ranked.

•

Non-GAAP Net Revenue

•

Non-GAAP Net Revenue Growth

•

Performance Compensation EBITDA

•

Performance Compensation EBITDA Margin

TABLE OF CONTENTS

PROPOSAL TWO:
ADVISORY VOTE ON EXECUTIVE COMPENSATION

The Dodd-Frank Wall Street Reform and Consumer Protection Act added Section 14A to the Exchange Act, which requires that we provide our shareholders with the opportunity to vote to approve, on a nonbinding, advisory basis, the compensation of our named executive officers as disclosed in this proxy statement pursuant to Item 402 of Regulation S-K (including in the compensation discussion and analysis, compensation tables and accompanying narrative disclosures). This advisory vote is commonly referred to as a “say-on-pay” vote. At the annual meeting of our shareholders held on July 17, 2025, a majority of our shareholders voted, on an advisory basis, in favor of our holding say-on-pay votes on an annual basis and, as reported in our current report on Form 8-K filed on July 22, 2025, our board of directors has decided to hold a say-on-pay vote every year until the next required advisory vote on the frequency of the say-on-pay vote at the 2029 annual meeting of our shareholders.

As described in greater detail in the section of this proxy statement entitled “Compensation of Directors and Executive Officers—Compensation discussion and analysis—Executive summary” above, we seek to closely align the interests of our executive officers with the interests of our shareholders. Our compensation committee has carefully designed our executive officer compensation program to provide competitive compensation to our executive officers that rewards them for the achievement of short-term and long-term strategic and operational goals, and the achievement of increased total shareholder return, while at the same time avoiding encouraging unnecessary or excessive risk-taking. We encourage you to carefully review the compensation discussion and analysis above for a complete discussion of the factors underlying the structure of our executive officer compensation program.

We are asking you to indicate your support for the compensation of our named executive officers as described in this proxy statement. The vote on this proposal is not intended to address any specific element of compensation, but rather relates to the overall compensation of our named executive officers, as described in this proxy statement pursuant to Item 402 of Regulation S-K (including in the compensation discussion and analysis, compensation tables and accompanying narrative disclosures).

This vote is advisory, which means that this vote on executive compensation will not be binding on us, our board of directors or our compensation committee. Nonetheless, our compensation committee will consider the outcome of this vote in deciding whether to take any action as a result of this vote and when making future executive officer compensation decisions. A majority of the votes properly cast at the annual meeting will be necessary to approve this proposal.

Accordingly, we are asking our shareholders to vote for the following at the annual meeting:

“VOTED, that, on an advisory basis, the compensation paid to our named executive officers, as disclosed in the proxy statement filed by CRA International, Inc. on April 24, 2026, pursuant to Item 402 of Regulation S-K (including in the compensation discussion and analysis, compensation tables and accompanying narrative disclosures) be, and it hereby is, approved.”

Our board of directors recommends that you vote FOR the approval, on an advisory basis, of the compensation paid to our named executive officers, as disclosed in this proxy statement pursuant to Item 402 of Regulation S-K.

TABLE OF CONTENTS

EQUITY COMPENSATION PLANS

The following table provides information, as of January 3, 2026, regarding shares authorized for issuance under our equity compensation plans, including individual compensation arrangements.

Equity Compensation Plan Information as of End of Fiscal 2025

Plan category	Number of shares to be issued upon exercise of outstanding options, warrants and rights (#) (a)		Weighted-average exercise price of outstanding options, warrants and rights ($) (b)		Number of shares remaining available for future issuance under equity compensation plans (excluding shares reflected in column (a)) (#) (c)
Equity compensation plans approved by shareholders		127,913(1)		46.15(2)		760,099(3)
Equity compensation plans not approved by stockholders		—		—		—
Total		127,913(1)		46.15(2)		760,099(3)

(1)

Amount reported consists of the following equity awards granted under our shareholder approved amended and restated 2006 equity incentive plan and outstanding as of the end of fiscal 2025: 45,200 shares underlying stock option awards, 36,329 shares underlying time-vesting restricted stock unit awards, 11,469 shares underlying performance-vesting restricted stock unit awards for which the performance conditions had been determined as of the end of fiscal 2025, and 34,915 shares underlying performance-vesting restricted stock unit awards for which the performance conditions had not been determined as of the end of fiscal 2025 (assuming target performance will be achieved). The number of shares underlying performance-vesting restricted stock unit awards for which the performance conditions had not been determined as of the end of fiscal 2025 (assuming that their highest level of performance will be achieved) is 45,311.

(2)

Amount reported is the weighted-average exercise price of the 45,200 stock options reported in column (a); the weighted-average remaining life of these stock options is 2.44 years.

(3)

Amount reported consists of 548,322 shares of common stock reserved for future issuance under our amended and restated 2006 equity incentive plan and 211,777 shares of common stock reserved for future issuance under our 1998 employee stock purchase plan, which is a tax-qualified plan under Section 423 of the Internal Revenue Code.

TABLE OF CONTENTS

REPORT OF THE AUDIT COMMITTEE

Our board of directors appointed an audit committee to, among other things, monitor the integrity of the Company’s consolidated financial statements, system of internal controls, and the independence and performance of its independent registered public accountants. The audit committee also selects the Company’s independent registered public accountants. The audit committee is governed by a written charter adopted by our board of directors. A current copy of the audit committee charter is available through the Investor Relations page of our website at www.crai.com.

During fiscal 2025, the audit committee consisted of three non-employee directors. Each member of the audit committee is or was “independent” within the meaning of the rules of the Nasdaq Global Select Market.

Our management is responsible for the Company’s financial reporting process, including its system of internal controls, and for the preparation of the Company’s consolidated financial statements in accordance with generally accepted accounting principles. The Company’s independent registered public accountants are responsible for auditing those financial statements. Our responsibility is to monitor and review these processes. However, we are not professionally engaged in the practice of accounting or auditing. We have relied, without independent verification, on the information provided to us and on the representations made by our management and independent registered public accountants.

In fulfilling our oversight responsibilities, we discussed with representatives of Grant Thornton LLP (“GT” or “Grant Thornton”) our independent registered public accountants for fiscal 2025, the overall scope and plans for their audit of our consolidated financial statements for fiscal 2025. We met with them, with and without our management present, to discuss the results of their audits and their evaluations of our internal controls and the overall quality of our financial reporting. We reviewed and discussed our audited consolidated financial statements for fiscal 2025 with our management and independent registered public accountants.

In addition, we reviewed the report of our management contained in our annual report on Form 10-K for the fiscal year ended January 3, 2026, filed with the SEC, as well as GT’s Report of Independent Registered Public Accounting Firm included in the Company’s annual report on Form 10-K for the fiscal year ended January 3, 2026 related to its audit of (1) the Company’s consolidated financial statements and (2) the effectiveness of the Company’s internal control over financial reporting. We discussed with the Company’s independent registered public accountants the matters required to be discussed by Auditing Standard No. 1301, Communications with Audit Committees, as adopted by the Public Company Accounting Oversight Board, including a discussion of the Company’s accounting principles, the application of those principles, and the other matters we were required to discuss with the Company’s independent registered public accountants under generally accepted auditing standards. In addition, we received from the Company’s independent registered public accountants a letter containing the written disclosures required by applicable standards of the Public Company Accounting Oversight Board and discussed the disclosures with them, as well as other matters relevant to their independence from our management and the Company. In evaluating the independence of the Company’s independent registered public accountants, we considered the fact that all audit-related services, tax services and other services for fiscal 2025 were pre-approved by the audit committee, which determined that such services would not impair the independence of the auditor and are consistent with the Securities and Exchange Commission’s rules on auditor independence.

Based on our review and these meetings, discussions and reports, and subject to the limitations on our role and responsibilities referred to above and in the Company’s audit committee charter, we recommended to our board of directors that the Company’s audited consolidated financial statements for fiscal 2025 be included in the Company’s annual report on Form 10-K for fiscal 2025 filed on February 26, 2026.

The audit committee
Richard Booth (Chair)
Karen Keenan
Alva Taylor, Ph.D.

TABLE OF CONTENTS

PROPOSAL THREE:
RATIFICATION OF APPOINTMENT OF
INDEPENDENT REGISTERED PUBLIC ACCOUNTANTS

Overview

Proposal Three concerns the ratification of the appointment by our audit committee of Grant Thornton LLP to be our independent registered public accountants for our fiscal year ending January 2, 2027.

The report of Grant Thornton on our consolidated financial statements as of and for the year ended January 3, 2026, did not contain an adverse opinion or a disclaimer of opinion and was not qualified or modified as to uncertainty, audit scope or accounting principles. For the fiscal year ended January 3, 2026, there were no “reportable events” as that term is defined in Item 304(a)(1)(v) of Regulation S-K.

Under rules of the Securities and Exchange Commission and the Nasdaq Global Select Market, appointment of our independent registered public accountants is the direct responsibility of our audit committee.

Although ratification of this appointment by our shareholders is not required by law, our board of directors believes that seeking shareholder ratification is a good practice that provides shareholders an avenue to express their views on this important matter.

Our board of directors recommends that shareholders vote to ratify the appointment of Grant Thornton as our auditors for the fiscal year ending January 2, 2027. If our shareholders do not ratify the appointment of Grant Thornton, our audit committee may, but is not required to, reconsider its decision. In any case, our audit committee may, in its discretion, appoint new independent registered public accountants at any time during the year if it believes that such change would be in our best interest and the best interest of our shareholders. We expect that representatives of Grant Thornton will be present at the annual meeting. They will have an opportunity to make a statement if they wish and will be available to respond to appropriate questions from shareholders.

Our board of directors recommends that you vote FOR Proposal Three to ratify the appointment by our audit committee of Grant Thornton LLP as our independent registered public accountants for fiscal 2026.

TABLE OF CONTENTS

PRINCIPAL ACCOUNTANT FEES AND SERVICES

Fees and Services

The following is a summary of the fees and out-of-pocket expenses for professional services rendered by GT, our current registered independent public accountants, for fiscal 2025 and fiscal 2024.

Fee category	Fiscal 2025			Fiscal 2024
Audit fees		$	1,888,676		$	1,828,325
Audit-related fees			—			—
Tax fees		$	69,300		$	87,230
All other fees			—			—
Total fees		$	1,957,976		$	1,915,555

Audit fees

Audit fees comprise fees and out-of-pocket expenses for professional services necessary to perform an audit or review in accordance with the standards of the Public Company Accounting Oversight Board, including services rendered for the integrated audit of our annual financial statements and the effectiveness of our internal control over financial reporting and the review of our quarterly financial statements. Audit fees also include fees for services that are normally provided in connection with statutory and regulatory financial statement filings.

Audit-related fees

In fiscal 2025 and fiscal 2024, GT did not perform any assurance or related services for us that were reasonably related to the performance of the audit or review of our financial statements, except as disclosed under the heading “Audit fees” above.

Tax fees

In fiscal 2025 and fiscal 2024, GT performed tax services that were pre-approved by our audit committee, which determined that such services would not impair the independence of the auditor and were consistent with the Securities and Exchange Commission’s rules on auditor independence.

All other fees

In fiscal 2025 and fiscal 2024, GT did not perform any other services for us other than those disclosed under the headings “Audit fees” and “Tax fees” above.

Pre-approval policies and procedures

Our audit committee pre-approves each engagement for audit or non-audit services before we engage our independent registered public accountants to provide those services. Our audit committee has also delegated to the chair of the committee the authority to pre-approve audit and non-audit services that the chair determines in good faith would not impair the independence of our independent registered public accountants. The chair of our audit committee must notify the other members of the committee of any audit or non-audit service that he pre-approves under this delegation of authority. Any other audit and non-audit services require pre-approval by the entire audit committee.

Our management may not engage our independent registered public accountants without explicit approval by our audit committee. None of the services provided by GT for fiscal 2025 was obtained in reliance on the waiver of the pre-approval requirement permitted by the Securities and Exchange Commission’s regulations.

TABLE OF CONTENTS

SHAREHOLDER PROPOSALS

Shareholder proposals for inclusion in our proxy materials relating to the 2027 annual meeting of our shareholders must be received by us at our executive offices no later than January 30, 2027 or, if the date of that meeting is more than 30 calendar days before or after July 16, 2027, a reasonable time before we begin to print and send our proxy materials with respect to that meeting.

In addition, our by-laws provide that a shareholder desiring to bring business before any meeting of shareholders or to nominate any person for election to our board of directors must give timely written notice to our secretary in accordance with the procedural requirements set forth in our by-laws. In the case of a regularly scheduled annual meeting, written notice must be delivered or mailed to and received at our principal executive offices not less than 60 days nor more than 90 days before the first Monday in May in the year of the annual meeting (the default date for such meetings set in our by-laws), must describe the business to be brought before the meeting, and must provide specific information about the proposing shareholder, other supporters of the proposal, their stock ownership and their interest in the proposed business. If we hold the 2027 annual meeting of our shareholders before May 3, 2027, and if we give less than 70 days’ notice or prior public disclosure of the date of that meeting, then the shareholder’s notice must be delivered or mailed to and received at our principal executive offices not later than the close of business on the tenth day after the earlier of (1) the day on which we mail notice of the date of the annual meeting and (2) the day on which we publicly disclose the date of the annual meeting. If we hold the 2027 annual meeting of our shareholders on or after May 3, 2027, in order to bring an item of business before the meeting in accordance with our by-laws, a shareholder must deliver the requisite notice of that item of business to us between February 2, 2027 and March 4, 2027. In addition, to comply with universal proxy rules, any notice of a solicitation of proxies in support of director nominees other than our nominees must set forth the information required by Rule 14a-19 under the Exchange Act and be postmarked or transmitted electronically to us at our principal executive office no later than May 17, 2027, or, if the date of the 2027 annual meeting has changed by more than 30 calendar days from the 2026 annual meeting, then by the later of 60 calendar days prior to the date of the 2027 annual meeting or the 10th calendar day after the day on which we first publicly announce the date of the 2027 annual meeting.

AVAILABLE INFORMATION

Shareholders of record on May 22, 2026 will receive this proxy statement and our annual report to shareholders, which contains detailed financial information about us. The annual report is not incorporated herein and is not deemed a part of this proxy statement.

TABLE OF CONTENTS

[MISSING IMAGE: px_26craproxy01pg01-bw.jpg]

Your vote matters – here’s how to vote!You may vote online or by phone instead of mailing this card.Votes submitted electronically mustbe received by July 16, 2026 at1:00 AM EDT.OnlineGo to www.envisionreports.com/CRAIor scan the QR code — login details arelocated in the shaded bar below.PhoneCall toll free 1-800-652-VOTE (8683) withinthe USA, US territories and CanadaSave paper, time and money!Sign up for electronic delivery atwww.envisionreports.com/CRAIUsing a black ink pen, mark your votes with an X as shown in this example.Please do not write outside the designated areas.Annual Meeting Proxy Cardq IF VOTING BY MAIL, SIGN, DETACH AND RETURN THE BOTTOM PORTION IN THE ENCLOSED ENVELOPE.qProposals — The Board of Directors recommends a vote FOR A the listed nominees and FOR Proposals 2 and 3.1. To consider and vote upon the election of two Class I Directors:For Withhold For Withhold01 - Richard Booth 02 - Christine DetrickFor Against Abstain For Against Abstain2. To approve, on an advisory basis, the compensation paid toCRA’s named executive officers, as disclosed in the proxystatement for the 2026 meeting of its shareholders.3. To ratify the appointment by our audit committee of GrantThornton LLP as our independent registered public accountantsfor our fiscal year ending January 2, 2027.B Authorized Signatures — This section must be completed for your vote to count. Please date and sign below.Please sign exactly as name(s) appears hereon. Joint owners should each sign. When signing as attorney, executor, administrator, corporate officer, trustee, guardian, or custodian, please givefull title.Date (mm/dd/yyyy) — Please print date below. Signature 1 — Please keep signature within the box. Signature 2 — Please keep signature within the box.

TABLE OF CONTENTS

[MISSING IMAGE: px_26craproxy01pg02-bw.jpg]

The 2026 Annual Meeting of Shareholders of CRA International, Inc. will be held onThursday, July 16, 2026, at 8:00 AM EDT at the offices of CRA International, Inc., located at200 Clarendon Street, 9th Floor, Boston, Massachusetts 02116Small steps make an impact.Help the environment by consenting to receive electronicdelivery, sign up at www.envisionreports.com/CRAITHIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS OF CRA INTERNATIONAL, INC.THE BOARD OF DIRECTORS RECOMMENDS A VOTE FOR EACH NOMINEE LISTED IN PROPOSAL 1 AND FORPROPOSALS 2 AND 3.CRA International, Inc.’s Annual Meeting of Shareholders will be held on Thursday, July 16, 2026, at 8:00 AM EDT at the offices of CRA International, Inc., located at200 Clarendon Street, 9th Floor, Boston, Massachusetts 02116Proxy for Annual Meeting of Shareholders to be held on July 16, 2026The undersigned shareholder of CRA International, Inc. (“CRA”), revoking all prior proxies, hereby appoints Paul Maleh and Jonathan Yellin, and each acting singly, proxies,with full power of substitution, to vote all shares of capital stock of CRA that the undersigned is entitled to vote at the Annual Meeting of Shareholders of CRA to be held onThursday, July 16, 2026, beginning at 8:00 AM EDT, and at any adjournments or postponements thereof, upon the matters set forth in the Notice of Annual Meeting datedMay 29, 2026, and the related Proxy Statement, and in their discretion upon any business that may properly come before the meeting or any adjournment or postponementthereof. Attendance of the undersigned at the Annual Meeting or any adjournment or postponement thereof will not be deemed to revoke this proxy unless the undersignedshall affirmatively indicate the intention of the undersigned to vote the shares represented hereby in person prior to the exercise of this proxy.THE SHARES REPRESENTED BY THIS PROXY WILL BE VOTED AS DIRECTED. IF NO DIRECTION IS GIVEN WITH RESPECT TO A PROPOSAL, THE SHARES REPRESENTED BY THISPROXY WILL BE VOTED FOR EACH NOMINEE LISTED IN PROPOSAL 1 AND FOR PROPOSALS 2 AND 3, OR OTHERWISE IN ACCORDANCE WITH THE RECOMMENDATION OF THEBOARD OF DIRECTORS.Please promptly date and sign this proxy and mail it in the enclosed envelope to ensure representation of your shares. No postage need be affixed if mailed in the United States.Proxy - CRA International, Inc.C Non-Voting Itemsq IF VOTING BY MAIL, SIGN, DETACH AND RETURN THE BOTTOM PORTION IN THE ENCLOSED ENVELOPE.qMeeting AttendanceMark box to the right ifyou plan to attend theAnnual Meeting.Change of Address — Please print new address below.

DEF 14A 0001053706 false 0001053706 2024-12-29 2026-01-03 0001053706 2023-12-31 2024-12-28 0001053706 2023-01-01 2023-12-30 0001053706 2022-01-02 2022-12-31 0001053706 2021-01-03 2022-01-01 0001053706 ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember ecd:PeoMember 2024-12-29 2026-01-03 0001053706 ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember ecd:PeoMember 2024-12-29 2026-01-03 0001053706 ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember ecd:PeoMember 2024-12-29 2026-01-03 0001053706 ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember ecd:PeoMember 2024-12-29 2026-01-03 0001053706 ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember ecd:PeoMember 2024-12-29 2026-01-03 0001053706 ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember ecd:PeoMember 2024-12-29 2026-01-03 0001053706 ecd:DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember ecd:PeoMember 2024-12-29 2026-01-03 0001053706 ecd:EqtyAwrdsAdjsMember ecd:PeoMember 2024-12-29 2026-01-03 0001053706 ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember ecd:NonPeoNeoMember 2024-12-29 2026-01-03 0001053706 ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember ecd:NonPeoNeoMember 2024-12-29 2026-01-03 0001053706 ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember ecd:NonPeoNeoMember 2024-12-29 2026-01-03 0001053706 ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember ecd:NonPeoNeoMember 2024-12-29 2026-01-03 0001053706 ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember ecd:NonPeoNeoMember 2024-12-29 2026-01-03 0001053706 ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember ecd:NonPeoNeoMember 2024-12-29 2026-01-03 0001053706 ecd:DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember ecd:NonPeoNeoMember 2024-12-29 2026-01-03 0001053706 ecd:EqtyAwrdsAdjsMember ecd:NonPeoNeoMember 2024-12-29 2026-01-03 0001053706 1 2024-12-29 2026-01-03 0001053706 2 2024-12-29 2026-01-03 0001053706 3 2024-12-29 2026-01-03 0001053706 4 2024-12-29 2026-01-03 iso4217:USD xbrli:pure

Source: View Original Filing on SEC EDGAR

FAQ

What key items will CRAI shareholders vote on at the 2026 annual meeting?

Shareholders will vote on three main proposals. These are electing two Class I directors to three-year terms, approving on an advisory basis the compensation of named executive officers, and ratifying Grant Thornton LLP as independent registered public accountants for the fiscal year ending January 2, 2027.

How is CRAI’s board structured and who is considered independent?

The board has eight directors divided into three staggered classes. All directors except CEO and chairman Paul Maleh are independent under Nasdaq rules. Committees (audit, compensation, nominating/governance) are fully independent, and two directors are designated audit committee financial experts by the board.

How are CRAI’s non-employee directors compensated?

Non-employee directors receive cash retainers and equity. In fiscal 2025, each received an $85,000 annual board fee, additional cash for committee and lead director roles, and a restricted stock award valued at about $125,000, vesting over four years to support long-term alignment with shareholders.

What is CRAI’s approach to executive compensation and incentives?

Executive pay combines salary with significant at-risk incentives. Annual cash bonuses depend on financial and individual goals, while long-term incentives use restricted stock units and performance-vesting RSUs tied to revenue growth and profitability, plus stock ownership guidelines and a clawback policy to align management with shareholder interests.

Who are CRAI’s largest institutional shareholders above 5% ownership?

Several institutions hold more than five percent stakes. FMR LLC reports beneficial ownership of 583,841 shares (9.0%), BlackRock, Inc. holds 501,133 shares (7.8%), and Copeland Capital Management, LLC holds 361,270 shares (5.6%), based on recent Schedule 13G and 13G/A filings.

Where will CRAI’s 2026 annual meeting be held and how can materials be accessed?

The meeting will be held at CRA’s Boston offices. The location is 200 Clarendon Street, 9th Floor, Boston, Massachusetts, at 8:00 a.m. eastern daylight time on July 16, 2026. The proxy statement and 2025 annual report will be available at www.edocumentview.com/CRAI by May 29, 2026.

Executive pay and board elections at CRA International (NASDAQ: CRAI)

Rhea-AI Filing Summary

Positive

Negative

Key Figures

Key Terms

Compensation Summary

FAQ

What key items will CRAI shareholders vote on at the 2026 annual meeting?

How is CRAI’s board structured and who is considered independent?

How are CRAI’s non-employee directors compensated?

What is CRAI’s approach to executive compensation and incentives?

Who are CRAI’s largest institutional shareholders above 5% ownership?

Where will CRAI’s 2026 annual meeting be held and how can materials be accessed?